{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:08:46Z","timestamp":1789034926688,"version":"build-2803163510"},"reference-count":297,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Japan Agency of Medical Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"DOI":"10.1186\/s41182-026-01048-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:20:08Z","timestamp":1789032008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comprehensive overview of monkeypox virus disease"],"prefix":"10.1186","volume":"54","author":[{"given":"Ijaz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmad Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Urano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8986-6307","authenticated-orcid":false,"given":"Mya Myat","family":"Ngwe Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"1048_CR1","unstructured":"Current ICTV Taxonomy release|ICTV. 2022. https:\/\/ictv.global\/taxonomy."},{"issue":"2","key":"1048_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14744\/ejmo.2022.2022","volume":"6","author":"RA Okyay","year":"2022","unstructured":"Okyay RA, Bayrak E, Kaya E, \u015eahin AR, Ko\u00e7yi\u011fit BF, Ta\u015fdo\u011fan AM, et al. Another epidemic in the shadow of COVID-19 pandemic: a review of monkeypox. Eurasian J Med Oncol. 2022;6(2):95\u20139. https:\/\/doi.org\/10.14744\/ejmo.2022.2022.","journal-title":"Eurasian J Med Oncol"},{"issue":"11","key":"1048_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/v12111257","volume":"12","author":"E Alakunle","year":"2020","unstructured":"Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020;12(11):1257. https:\/\/doi.org\/10.3390\/v12111257.","journal-title":"Viruses"},{"issue":"3","key":"1048_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/oxfordjournals.bmb.a011720","volume":"54","author":"DL Heymann","year":"1998","unstructured":"Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1998;54(3):693\u2013702. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a011720.","journal-title":"Br Med Bull"},{"issue":"2","key":"1048_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1699-0463.1959.tb00328.x","volume":"46","author":"P Magnus","year":"1959","unstructured":"Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Acta Pathol Microbiol Scand. 1959;46(2):156\u201376. https:\/\/doi.org\/10.1111\/j.1699-0463.1959.tb00328.x.","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"6596","key":"1048_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1126\/science.add1583","volume":"376","author":"J Cohen","year":"2022","unstructured":"Cohen J. Monkeypox outbreak questions intensify as cases soar. Science. 2022;376(6596):902\u20133. https:\/\/doi.org\/10.1126\/science.add1583.","journal-title":"Science"},{"key":"1048_CR7","doi-asserted-by":"crossref","unstructured":"World Health Organization. WHO recommends new name for monkeypox disease (mpox). 2022. https:\/\/www.who.int\/news\/item\/28-11-2022-who-recommends-new-name-for-monkeypox-disease.","DOI":"10.17712\/1658-3183.2624"},{"issue":"1","key":"1048_CR8","first-page":"56","volume":"39","author":"L Khodakevich","year":"1987","unstructured":"Khodakevich L, Szczeniowski M, Nambu-ma-Disu JZ, Marennikova S, Nakano J, et al. Monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone Zaire. Trop Geogr Med. 1987;39(1):56\u201363.","journal-title":"Trop Geogr Med"},{"issue":"8","key":"1048_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022. N Engl J Med. 2022;387(8):679\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2207323.","journal-title":"N Engl J Med"},{"issue":"2","key":"1048_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox\u2014a potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141. https:\/\/doi.org\/10.1371\/journal.pntd.0010141.","journal-title":"PLoS Negl Trop Dis"},{"key":"1048_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1029215","volume":"11","author":"SA Meo","year":"2023","unstructured":"Meo SA, Al-Khlaiwi T, Al Jassir FF, Meo AS. Impact of traveling on transmission trends of human monkeypox disease: worldwide data based observational analysis. Front Public Health. 2023;11:1029215. https:\/\/doi.org\/10.3389\/fpubh.2023.1029215.","journal-title":"Front Public Health"},{"issue":"5","key":"1048_CR12","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3201\/eid2805.220292","volume":"28","author":"V Costello","year":"2022","unstructured":"Costello V, Sowash M, Gaur A, Cardis M, Pasieka H, Wortmann G, et al. Imported monkeypox from international traveler, Maryland, USA, 2021. Emerg Infect Dis. 2022;28(5):1002\u20135. https:\/\/doi.org\/10.3201\/eid2805.220292.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"1048_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41579-022-00776-z","volume":"20","author":"EF Alakunle","year":"2022","unstructured":"Alakunle EF, Okeke MI. Monkeypox virus: a neglected zoonotic pathogen spreads globally. Nat Rev Microbiol. 2022;20(9):507\u20138. https:\/\/doi.org\/10.1038\/s41579-022-00776-z.","journal-title":"Nat Rev Microbiol"},{"key":"1048_CR14","unstructured":"World Health Organization. Multi-country outbreak of mpox, External situation report no. 64-26 March 2026. Geneva: WHO; 2026. https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report--64---26-march-2026."},{"key":"1048_CR15","unstructured":"World Health Organization. WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox-23 July 2022. 2022. https:\/\/www.who.int\/news-room\/speeches\/item\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022."},{"issue":"3","key":"1048_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","volume":"17","author":"PE Fine","year":"1988","unstructured":"Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17(3):643\u201350. https:\/\/doi.org\/10.1093\/ije\/17.3.643.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1048_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","volume":"156","author":"Z Jezek","year":"1987","unstructured":"Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156(2):293\u20138. https:\/\/doi.org\/10.1093\/infdis\/156.2.293.","journal-title":"J Infect Dis"},{"issue":"4","key":"1048_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","volume":"16","author":"A Karagoz","year":"2023","unstructured":"Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, et al. Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023;16(4):531\u201341. https:\/\/doi.org\/10.1016\/j.jiph.2023.02.003.","journal-title":"J Infect Public Health"},{"key":"1048_CR19","unstructured":"Nextstrain. Mpox all clades. https:\/\/nextstrain.org\/mpox\/all-clades."},{"key":"1048_CR20","volume-title":"Origin and evolution of viruses","year":"2008","unstructured":"Domingo E, Parrish CR, Holland JJ, editors. Origin and evolution of viruses. 2nd ed. Amsterdam: Elsevier Academic Press; 2008.","edition":"2nd ed"},{"issue":"3","key":"1048_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3855\/jidc.258","volume":"2","author":"N Moussatch\u00e9","year":"2008","unstructured":"Moussatch\u00e9 N, Damaso CR, McFadden G. When good vaccines go wild: feral orthopoxvirus in developing countries and beyond. J Infect Dev Ctries. 2008;2(3):156\u201373. https:\/\/doi.org\/10.3855\/jidc.258.","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"1048_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","volume":"17","author":"S Lewis-Jones","year":"2004","unstructured":"Lewis-Jones S. Zoonotic poxvirus infections in humans. Curr Opin Infect Dis. 2004;17(2):81\u20139. https:\/\/doi.org\/10.1097\/00001432-200404000-00003.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"1048_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, et al. Human monkey-pox and smallpox viruses: genomic comparison. FEBS Lett. 2001;509(1):66\u201370. https:\/\/doi.org\/10.1016\/S0014-5793(01)03144-1.","journal-title":"FEBS Lett"},{"key":"1048_CR24","volume-title":"Principles of molecular virology","author":"AJ Cann","year":"2015","unstructured":"Cann AJ. Principles of molecular virology. 6th ed. Amsterdam: Academic Press; 2015.","edition":"6th ed"},{"issue":"1","key":"1048_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-6-188","volume":"6","author":"A Alkhalil","year":"2009","unstructured":"Alkhalil A, Strand S, Mucker E, Huggins JW, Jahrling PB, Ibrahim SM. Inhibition of monkeypox virus replication by RNA interference. Virol J. 2009;6(1):188. https:\/\/doi.org\/10.1186\/1743-422X-6-188.","journal-title":"Virol J"},{"key":"1048_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","volume":"225","author":"JR Weaver","year":"2008","unstructured":"Weaver JR, Isaacs SN. Monkeypox virus and insights into its immunomodulatory proteins. Immunol Rev. 2008;225:96\u2013113. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00691.x.","journal-title":"Immunol Rev"},{"issue":"1","key":"1048_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0042-6822(85)90111-4","volume":"143","author":"JJ Esposito","year":"1985","unstructured":"Esposito JJ, Knight JC. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology. 1985;143(1):230\u201351. https:\/\/doi.org\/10.1016\/0042-6822(85)90111-4.","journal-title":"Virology"},{"issue":"2","key":"1048_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3201\/eid2002.130118","volume":"20","author":"JR Kugelman","year":"2014","unstructured":"Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg Infect Dis. 2014;20(2):232\u20139. https:\/\/doi.org\/10.3201\/eid2002.130118.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"1048_CR29","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/molbev\/msq088","volume":"27","author":"C Firth","year":"2010","unstructured":"Firth C, Kitchen A, Shapiro B, Suchard MA, Holmes EC, Rambaut A. Using time-structured data to estimate evolutionary rates of double-stranded DNA viruses. Mol Biol Evol. 2010;27(9):2038\u201351. https:\/\/doi.org\/10.1093\/molbev\/msq088.","journal-title":"Mol Biol Evol"},{"issue":"6670","key":"1048_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.adg8116","volume":"382","author":"\u00c1 O\u2019Toole","year":"2016","unstructured":"O\u2019Toole \u00c1, Neher RA, Ndodo N, Borges V, Gannon B, Gomes JP, et al. APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016. Science. 2016;382(6670):595\u2013600. https:\/\/doi.org\/10.1126\/science.adg8116.","journal-title":"Science"},{"issue":"10","key":"1048_CR31","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","volume":"86","author":"AM Likos","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005;86(10):2661\u201372. https:\/\/doi.org\/10.1099\/vir.0.81215-0.","journal-title":"J Gen Virol"},{"issue":"5","key":"1048_CR32","first-page":"613","volume":"46","author":"EM Marennikova \u0160eluhina","year":"1972","unstructured":"Marennikova \u0160eluhina EM, Mal\u2019ceva NN, Ladnyj ID. Poxviruses isolated from clinically ill and asymptomatically infected monkeys and a chimpanzee. Bull World Health Organ. 1972;46(5):613\u201320.","journal-title":"Bull World Health Organ"},{"key":"1048_CR33","unstructured":"World Health Organization. Global Mpox Trends. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/."},{"issue":"38","key":"1048_CR34","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509","volume":"23","author":"A Vaughan","year":"2018","unstructured":"Vaughan A, Aarons E, Astbury J, Balasegaram S, Beadsworth M, Beck CR, et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill. 2018;23(38):1800509. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.38.1800509.","journal-title":"Euro Surveill"},{"key":"1048_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2025.101224","volume":"21","author":"Y Ge","year":"2025","unstructured":"Ge Y, Wang Y, Zhou Z, Zhang Z, Tian Y, Feng Y, et al. Associations between the 2022 global mpox outbreak and multifaceted factors: a multi-geographical retrospective study. One Health. 2025;21:101224. https:\/\/doi.org\/10.1016\/j.onehlt.2025.101224.","journal-title":"One Health"},{"issue":"8","key":"1048_CR36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","volume":"28","author":"J Isidro","year":"2022","unstructured":"Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022;28(8):1569\u201372. https:\/\/doi.org\/10.1038\/s41591-022-01907-y.","journal-title":"Nat Med"},{"issue":"7","key":"1048_CR37","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.vaccine.2023.12.086","volume":"42","author":"FM Giorgi","year":"2024","unstructured":"Giorgi FM, Pozzobon D, Di Meglio A, Mercatelli D. Genomic and transcriptomic analysis of the recent mpox outbreak. Vaccine. 2024;42(7):1841\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.086.","journal-title":"Vaccine"},{"issue":"24","key":"1048_CR38","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1016\/j.cub.2016.10.061","volume":"26","author":"AT Duggan","year":"2016","unstructured":"Duggan AT, Perdomo MF, Piombino-Mascali D, Marciniak S, Poinar D, Emery MV, et al. 17th century variola virus reveals the recent history of smallpox. Curr Biol. 2016;26(24):3407\u201312. https:\/\/doi.org\/10.1016\/j.cub.2016.10.061.","journal-title":"Curr Biol"},{"issue":"5","key":"1048_CR39","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41591-026-04256-2","volume":"32","author":"F Koukouikila-Koussounda","year":"2026","unstructured":"Koukouikila-Koussounda F, Kwe Yinda C, Issamou Mayangue P, Aymard Eyenet Boussam D, Golmard Elenga R, Hosanna Lenguiya L, et al. Evidence of monkeypox virus clade IIb lineage A.2.2 in the Republic of the Congo and co-circulation of clade Ia, Ib and clade IIb. Nat Med. 2026;32(5):1666\u201370. https:\/\/doi.org\/10.1038\/s41591-026-04256-2.","journal-title":"Nat Med"},{"issue":"8","key":"1048_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001769","volume":"20","author":"C Happi","year":"2022","unstructured":"Happi C, Adetifa I, Mbala P, Njouom R, Nakoune E, Happi A, et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. 2022;20(8):e3001769. https:\/\/doi.org\/10.1371\/journal.pbio.3001769.","journal-title":"PLoS Biol"},{"key":"1048_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2025.101232","volume":"21","author":"B Akhavan","year":"2025","unstructured":"Akhavan B, Ahmed AB, To W, Alkhouri S, Batra K. From forest to frontline: a comprehensive review of mpox\u2019s global leap and viral evolution (2022\u20132024). One Health. 2025;21:101232. https:\/\/doi.org\/10.1016\/j.onehlt.2025.101232.","journal-title":"One Health"},{"issue":"6","key":"1048_CR42","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1007\/s11357-022-00659-4","volume":"44","author":"C Chakraborty","year":"2022","unstructured":"Chakraborty C, Bhattacharya M, Sharma AR, Dhama K. Evolution, epidemiology, geographical distribution, and mutational landscape of newly emerging monkeypox virus. GeroScience. 2022;44(6):2895\u2013911. https:\/\/doi.org\/10.1007\/s11357-022-00659-4.","journal-title":"GeroScience"},{"key":"1048_CR43","unstructured":"World Health Organization. Multi-country monkeypox outbreak in non-endemic countries: Update. 2022. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON388."},{"issue":"2","key":"1048_CR44","first-page":"165","volume":"58","author":"JG Breman","year":"1980","unstructured":"Breman JG, Kalisa-Ruti SMV, Zanotto E, Gromyko AI, Arita I. Human monkeypox, 1970\u201379. Bull World Health Organ. 1980;58(2):165\u201372.","journal-title":"Bull World Health Organ"},{"key":"1048_CR45","volume-title":"The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication, Geneva, December 1979","author":"World Health Organization","year":"1980","unstructured":"World Health Organization. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication, Geneva, December 1979. Geneva: WHO; 1980."},{"key":"1048_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000416462","volume-title":"Human monkeypox","author":"Z Jezek","year":"1988","unstructured":"Jezek Z, Fenner F. Epidemiology of human monkeypox. In: Human monkeypox. Basel: S. Karger AG; 1988. p. 81\u2013110. https:\/\/doi.org\/10.1159\/000416462."},{"issue":"1","key":"1048_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jmv.1890010107","volume":"1","author":"JJ Esposito","year":"1977","unstructured":"Esposito JJ, Obijeski JF, Nakano JH. Serological relatedness of monkeypox, variola, and vaccinia viruses. J Med Virol. 1977;1(1):35\u201347. https:\/\/doi.org\/10.1002\/jmv.1890010107.","journal-title":"J Med Virol"},{"issue":"3","key":"1048_CR48","first-page":"250","volume":"20","author":"NN Maltseva","year":"1976","unstructured":"Maltseva NN, Marennikova SS. A method for serological differentiation of closely related poxviruses. Acta Virol. 1976;20(3):250\u20132.","journal-title":"Acta Virol"},{"issue":"8","key":"1048_CR49","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1128\/JCM.40.8.2919-2921.2002","volume":"40","author":"H Meyer","year":"2002","unstructured":"Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, et al. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol. 2002;40(8):2919\u201321. https:\/\/doi.org\/10.1128\/JCM.40.8.2919-2921.2002.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1048_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4269\/ajtmh.2005.73.428","volume":"73","author":"LA Learned","year":"2005","unstructured":"Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, et al. Extended inter-human transmission of monkeypox in a hospital community in the Republic of Congo, 2003. Am J Trop Med Hyg. 2005;73(2):428\u201334.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"1048_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002118","volume":"7","author":"AW Rimoin","year":"2013","unstructured":"Rimoin AW, Hotez PJ. NTDs in the heart of darkness: the Democratic Republic of Congo\u2019s unknown burden of neglected tropical diseases. PLoS Negl Trop Dis. 2013;7(7):e2118. https:\/\/doi.org\/10.1371\/journal.pntd.0002118.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1048_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3201\/eid2502.181222","volume":"25","author":"RH Doshi","year":"2019","unstructured":"Doshi RH, Guagliardo SAJ, Doty JB, Babeaux AD, Matheny A, Burgado J, et al. Epidemiologic and ecologic investigations of monkeypox, Likouala Department, Republic of the Congo, 2017. Emerg Infect Dis. 2019;25(2):273\u201381. https:\/\/doi.org\/10.3201\/eid2502.181222.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"1048_CR53","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2406.180017","volume":"24","author":"A Yinka-Ogunleye","year":"2017","unstructured":"Yinka-Ogunleye A, Aruna O, Ogoina D, Aworabhi N, Eteng W, Badaru S, et al. Reemergence of human monkeypox in Nigeria, 2017. Emerg Infect Dis. 2017;24(6):1149\u201351. https:\/\/doi.org\/10.3201\/eid2406.180017.","journal-title":"Emerg Infect Dis"},{"issue":"32","key":"1048_CR54","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.15585\/mmwr.mm7132e3","volume":"71","author":"Centers for Disease Control and Prevention","year":"2022","unstructured":"Centers for Disease Control and Prevention. Epidemiologic and clinical characteristics of monkeypox cases \u2014 United States, May 17\u2013July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(32):1018\u201322. https:\/\/doi.org\/10.15585\/mmwr.mm7132e3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1048_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2025.101030","volume":"20","author":"A Bogacka","year":"2025","unstructured":"Bogacka A, Wroczynska A, Rymer W, Grzesiowski P, Kant R, Grzybek M, et al. Mpox unveiled: global epidemiology, treatment advances, and prevention strategies. One Health. 2025;20:101030. https:\/\/doi.org\/10.1016\/j.onehlt.2025.101030.","journal-title":"One Health"},{"issue":"Suppl 2","key":"1048_CR56","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1093\/infdis\/jiad504","volume":"229","author":"F Kabir","year":"2024","unstructured":"Kabir F, Plaisance E, Portman A, Marfo A, Cirrincione K, Silva D, et al. Mpox viral lineage analysis and technique development using next-generation sequencing approach. J Infect Dis. 2024;229(Suppl 2):S163\u201371. https:\/\/doi.org\/10.1093\/infdis\/jiad504.","journal-title":"J Infect Dis"},{"issue":"1","key":"1048_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41564-018-0296-2","volume":"4","author":"JT Ladner","year":"2019","unstructured":"Ladner JT, Lemey P, Pybus OG, Rambaut A, Holmes EC, et al. Tracking virus outbreaks in the twenty-first century. Nat Microbiol. 2019;4(1):10\u20139. https:\/\/doi.org\/10.1038\/s41564-018-0296-2.","journal-title":"Nat Microbiol"},{"issue":"9","key":"1048_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222612","volume":"14","author":"ZP Weiner","year":"2019","unstructured":"Weiner ZP, Salzer JS, LeMasters E, Ellison JA, Kondas AV, Morgan CN, et al. Characterization of monkeypox virus dissemination in the black-tailed prairie dog (Cynomys ludovicianus) through in vivo bioluminescent imaging. PLoS ONE. 2019;14(9):e0222612. https:\/\/doi.org\/10.1371\/journal.pone.0222612.","journal-title":"PLoS ONE"},{"issue":"8","key":"1048_CR59","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","volume":"19","author":"A Yinka-Ogunleye","year":"2017","unstructured":"Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human monkeypox in Nigeria in 2017\u201318: a clinical and epidemiological report. Lancet Infect Dis. 2017;19(8):872\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(19)30294-4.","journal-title":"Lancet Infect Dis"},{"key":"1048_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijid.2022.05.058","volume":"122","author":"N Haider","year":"2022","unstructured":"Haider N, Guitian J, Simons D, Asogun D, Ansumana R, Honeyborne I, et al. Increased outbreaks of monkeypox highlight gaps in actual disease burden in sub-Saharan Africa and in animal reservoirs. Int J Infect Dis. 2022;122:107\u201311. https:\/\/doi.org\/10.1016\/j.ijid.2022.05.058.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"1048_CR61","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs. 2022;82(9):1103\u201319. https:\/\/doi.org\/10.1007\/s40265-022-01742-y.","journal-title":"Drugs"},{"issue":"4","key":"1048_CR62","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","volume":"33","author":"E Petersen","year":"2019","unstructured":"Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027\u201343. https:\/\/doi.org\/10.1016\/j.idc.2019.03.001.","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"1048_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7589\/0090-3558-48.2.335","volume":"48","author":"CK Ellis","year":"2012","unstructured":"Ellis CK, Carroll DS, Lash RR, Peterson AT, Damon IK, Malekani J, et al. Ecology and geography of human monkeypox case occurrences across Africa. J Wildl Dis. 2012;48(2):335\u201347. https:\/\/doi.org\/10.7589\/0090-3558-48.2.335.","journal-title":"J Wildl Dis"},{"key":"1048_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00241","volume":"6","author":"N Sklenovsk\u00e1","year":"2018","unstructured":"Sklenovsk\u00e1 N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health. 2018;6:241. https:\/\/doi.org\/10.3389\/fpubh.2018.00241.","journal-title":"Front Public Health"},{"issue":"12","key":"1048_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028295","volume":"6","author":"CL Hutson","year":"2011","unstructured":"Hutson CL, Carroll DS, Gallardo-Romero N, Weiss S, Clemmons C, Hughes CM, et al. Monkeypox disease transmission in an experimental setting: prairie dog animal model. PLoS ONE. 2011;6(12):e28295. https:\/\/doi.org\/10.1371\/journal.pone.0028295.","journal-title":"PLoS ONE"},{"issue":"7913","key":"1048_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/d41586-022-01493-6","volume":"606","author":"M Kozlov","year":"2022","unstructured":"Kozlov M. Monkeypox outbreaks: 4 key questions researchers have. Nature. 2022;606(7913):238\u20139. https:\/\/doi.org\/10.1038\/d41586-022-01493-6.","journal-title":"Nature"},{"issue":"4","key":"1048_CR67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","volume":"37","author":"Q Gong","year":"2022","unstructured":"Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: a re-emergent threat to humans. Virol Sin. 2022;37(4):477\u201382. https:\/\/doi.org\/10.1016\/j.virs.2022.07.006.","journal-title":"Virol Sin"},{"issue":"8","key":"1048_CR68","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/pathogens11080924","volume":"11","author":"R Sah","year":"2022","unstructured":"Sah R, Abdelaal A, Reda A, Katamesh BE, Manirambona E, Abdelmonem H, et al. Monkeypox and its possible sexual transmission: where are we now with its evidence? Pathogens. 2022;11(8):924. https:\/\/doi.org\/10.3390\/pathogens11080924.","journal-title":"Pathogens"},{"issue":"1","key":"1048_CR69","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1080\/22221751.2022.2132882","volume":"11","author":"MM Hatmal","year":"2022","unstructured":"Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Ahmad S, Hasan H, Ahmad Suhaimi NA, et al. Comprehensive literature review of monkeypox. Emerg Microbes Infect. 2022;11(1):2600\u201331. https:\/\/doi.org\/10.1080\/22221751.2022.2132882.","journal-title":"Emerg Microbes Infect"},{"key":"1048_CR70","unstructured":"World Health Organization. Mpox. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mpox."},{"key":"1048_CR71","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004909","author":"D Meaney-Delman","year":"2022","unstructured":"Meaney-Delman D, Galang R, Petersen B, Jamieson D. A primer on monkeypox virus for obstetrician\u2013gynecologists: diagnosis, prevention, and treatment. Obstet Gynecol. 2022. https:\/\/doi.org\/10.1097\/AOG.0000000000004909.","journal-title":"Obstet Gynecol"},{"key":"1048_CR72","unstructured":"Centers for Disease Control and Prevention. Clinical considerations for mpox in people who are pregnant or breastfeeding. 2024. https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/pregnancy.html."},{"issue":"7","key":"1048_CR73","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/infdis\/jix342","volume":"216","author":"NK Kisalu","year":"2017","unstructured":"Kisalu NK, Mokili JL. Toward understanding the outcomes of monkeypox infection in human pregnancy. J Infect Dis. 2017;216(7):795\u20137. https:\/\/doi.org\/10.1093\/infdis\/jix342.","journal-title":"J Infect Dis"},{"issue":"7","key":"1048_CR74","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/infdis\/jix260","volume":"216","author":"PK Mbala","year":"2017","unstructured":"Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, et al. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis. 2017;216(7):824\u20138. https:\/\/doi.org\/10.1093\/infdis\/jix260.","journal-title":"J Infect Dis"},{"issue":"4","key":"1048_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010384","volume":"17","author":"PR Pittman","year":"2023","unstructured":"Pittman PR, Martin JW, Kingebeni PM, Tamfum JJM, Mwema G, Wan Q, et al. Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2023;17(4):e0010384. https:\/\/doi.org\/10.1371\/journal.pntd.0010384.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"1048_CR76","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/v15081649","volume":"15","author":"DA Schwartz","year":"2023","unstructured":"Schwartz DA, Pittman PR. Mpox (monkeypox) in pregnancy: viral clade differences and their associations with varying obstetrical and fetal outcomes. Viruses. 2023;15(8):1649. https:\/\/doi.org\/10.3390\/v15081649.","journal-title":"Viruses"},{"issue":"8","key":"1048_CR77","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","volume":"71","author":"D Ogoina","year":"2020","unstructured":"Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P, et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis. 2020;71(8):e210\u20134. https:\/\/doi.org\/10.1093\/cid\/ciaa143.","journal-title":"Clin Infect Dis"},{"key":"1048_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102402","volume":"49","author":"N Luna","year":"2022","unstructured":"Luna N, Ram\u00edrez AL, Mu\u00f1oz M, Ballesteros N, Pati\u00f1o LH, Casta\u00f1eda SA, et al. Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: emergence of a novel viral lineage? Travel Med Infect Dis. 2022;49:102402. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102402.","journal-title":"Travel Med Infect Dis"},{"issue":"10367","key":"1048_CR79","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(22)02187-0","volume":"400","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Palich R, Ghosn J, Walmsley S, Moschese D, Cortes CP, et al. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series. Lancet. 2022;400(10367):1953\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(22)02187-0.","journal-title":"Lancet"},{"key":"1048_CR80","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(22)02396-0","volume":"400","author":"A Rodriguez-Morales","year":"2022","unstructured":"Rodriguez-Morales A, Amer F. Monkeypox virus infection in women and non-binary people: uncommon or neglected? Lancet. 2022;400:1903\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(22)02396-0.","journal-title":"Lancet"},{"issue":"10370","key":"1048_CR81","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet. 2023;401(10370):60\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(22)02075-X.","journal-title":"Lancet"},{"issue":"11","key":"1048_CR82","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/S1473-3099(22)00612-0","volume":"22","author":"A Khalil","year":"2022","unstructured":"Khalil A, Samara A, O\u2019Brien P, Coutinho CM, Duarte G, Quintana SM, et al. Monkeypox in pregnancy: update on current outbreak. Lancet Infect Dis. 2022;22(11):1534\u20135. https:\/\/doi.org\/10.1016\/S1473-3099(22)00612-0.","journal-title":"Lancet Infect Dis"},{"key":"1048_CR83","unstructured":"Minist\u00e9rio da Sa\u00fade (Brazil). Boletins epidemiol\u00f3gicos: Mpox. 2022. https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/boletins\/epidemiologicos\/variola-dos-macacos."},{"issue":"1","key":"1048_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15585\/mmwr.mm7201a2","volume":"72","author":"LP Oakley","year":"2022","unstructured":"Oakley LP, Hufstetler K, O\u2019Shea J, Sharpe JD, McArdle C, Neelam V, et al. Mpox cases among cisgender women and pregnant persons - United States, May 11\u2013November 7, 2022. MMWR Morb Mortal Wkly Rep. 2022;72(1):9\u201314. https:\/\/doi.org\/10.15585\/mmwr.mm7201a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"1048_CR85","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ajog.2022.08.017","volume":"227","author":"P Dashraath","year":"2022","unstructured":"Dashraath P, Nielsen-Saines K, Rimoin A, Mattar CNZ, Panchaud A, Baud D. Monkeypox in pregnancy: virology, clinical presentation, and obstetric management. Am J Obstet Gynecol. 2022;227(6):849-61.e7. https:\/\/doi.org\/10.1016\/j.ajog.2022.08.017.","journal-title":"Am J Obstet Gynecol"},{"key":"1048_CR86","unstructured":"Pan American Health Organization. Situation report on mpox multi-country outbreak response\u2013Region of the Americas, No. 7, 3 March 2023. 2023. https:\/\/www.paho.org\/en\/mpox-situation-reports."},{"key":"1048_CR87","unstructured":"Tin A. U.S. spots first monkeypox case in a pregnant woman as cases climb. CBS News. 2022. https:\/\/www.cbsnews.com\/news\/monkeypox-pregnant-woman-baby-cases\/."},{"key":"1048_CR88","unstructured":"Infectious Diseases Society of America. CDC\/IDSA monkeypox: updates on testing, vaccination & treatment. 2022. https:\/\/www.idsociety.org\/multimedia\/clinician-calls\/cdcidsa-monkeypox-updates-on-testing-vaccination--treatment\/."},{"issue":"3","key":"1048_CR89","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12519-022-00618-1","volume":"19","author":"YM Dou","year":"2023","unstructured":"Dou YM, Yuan H, Tian HW. Monkeypox virus: past and present. World J Pediatr. 2023;19(3):224\u201330. https:\/\/doi.org\/10.1007\/s12519-022-00618-1.","journal-title":"World J Pediatr"},{"key":"1048_CR90","unstructured":"Centers for Disease Control and Prevention. Monkeypox: signs and symptoms. 2021. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/symptoms.html."},{"issue":"12","key":"1048_CR91","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","volume":"41","author":"GD Huhn","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41(12):1742\u201351. https:\/\/doi.org\/10.1086\/498115.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1048_CR92","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26531","volume":"14","author":"J Kaler","year":"2022","unstructured":"Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers D. Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation. Cureus. 2022;14(7):e26531. https:\/\/doi.org\/10.7759\/cureus.26531.","journal-title":"Cureus"},{"issue":"9","key":"1048_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005857","volume":"11","author":"L Osadebe","year":"2017","unstructured":"Osadebe L, Hughes CM, Shongo Lushima R, Kabamba J, Nguete B, Malekani J, et al. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo. PLoS Negl Trop Dis. 2017;11(9):e0005857. https:\/\/doi.org\/10.1371\/journal.pntd.0005857.","journal-title":"PLoS Negl Trop Dis"},{"key":"1048_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.634827","volume":"12","author":"CRS McEntire","year":"2021","unstructured":"McEntire CRS, Song KW, McInnis RP, Rhee JY, Young M, Williams E, et al. Neurologic manifestations of the World Health Organization\u2019s list of pandemic and epidemic diseases. Front Neurol. 2021;12:634827. https:\/\/doi.org\/10.3389\/fneur.2021.634827.","journal-title":"Front Neurol"},{"issue":"4","key":"1048_CR95","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.wem.2021.08.003","volume":"32","author":"JH Diaz","year":"2021","unstructured":"Diaz JH. The disease ecology, epidemiology, clinical manifestations, management, prevention, and control of increasing human infections with animal orthopoxviruses. Wilderness Environ Med. 2021;32(4):467\u201376. https:\/\/doi.org\/10.1016\/j.wem.2021.08.003.","journal-title":"Wilderness Environ Med"},{"issue":"8","key":"1048_CR96","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","volume":"22","author":"H Adler","year":"2022","unstructured":"Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(22)00228-6.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1048_CR97","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/tropicalmed1010008","volume":"1","author":"K Brown","year":"2016","unstructured":"Brown K, Leggat PA. Human monkeypox: current state of knowledge and implications for the future. Trop Med Infect Dis. 2016;1(1):8. https:\/\/doi.org\/10.3390\/tropicalmed1010008.","journal-title":"Trop Med Infect Dis"},{"key":"1048_CR98","doi-asserted-by":"publisher","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","volume":"29","author":"IK Damon","year":"2021","unstructured":"Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2021;29:D54\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.014.","journal-title":"Vaccine"},{"issue":"1","key":"1048_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01675-2","volume":"8","author":"J Lu","year":"2023","unstructured":"Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, et al. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther. 2023;8(1):458. https:\/\/doi.org\/10.1038\/s41392-023-01675-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"1048_CR100","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/v4050688","volume":"4","author":"B Moss","year":"2012","unstructured":"Moss B. Poxvirus cell entry: how many proteins does it take? Viruses. 2012;4(5):688\u2013707. https:\/\/doi.org\/10.3390\/v4050688.","journal-title":"Viruses"},{"key":"1048_CR101","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","volume":"60","author":"B Moss","year":"2016","unstructured":"Moss B. Membrane fusion during poxvirus entry. Semin Cell Dev Biol. 2016;60:89\u201396. https:\/\/doi.org\/10.1016\/j.semcdb.2016.07.015.","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"1048_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108896","volume":"24","author":"D Peruzzu","year":"2023","unstructured":"Peruzzu D, Fecchi K, Venturi G, Gagliardi MC. Repurposing amphotericin B and its liposomal formulation for the treatment of human mpox. Int J Mol Sci. 2023;24(10):8896. https:\/\/doi.org\/10.3390\/ijms24108896.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1048_CR103","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/jmv.25348","volume":"91","author":"AI Kabuga","year":"2019","unstructured":"Kabuga AI, El Zowalaty ME. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. J Med Virol. 2019;91(4):533\u201340. https:\/\/doi.org\/10.1002\/jmv.25348.","journal-title":"J Med Virol"},{"issue":"10","key":"1048_CR104","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum FM, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, R\u00e9nia L, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597\u2013613. https:\/\/doi.org\/10.1038\/s41577-022-00775-4.","journal-title":"Nat Rev Immunol"},{"key":"1048_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1132250","volume":"14","author":"L Niu","year":"2023","unstructured":"Niu L, Liang D, Ling Q, Zhang J, Li Z, Zhang D, et al. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments. Front Immunol. 2023;14:1132250. https:\/\/doi.org\/10.3389\/fimmu.2023.1132250.","journal-title":"Front Immunol"},{"key":"1048_CR106","unstructured":"World Health Organization. Diagnostic testing for the monkeypox virus (MPXV): interim guidance, 10 May 2024. Geneva: WHO; 2024. https:\/\/iris.who.int\/items\/0d980002-486a-4571-b633-1065b3e17150."},{"issue":"1","key":"1048_CR107","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1086\/595552","volume":"48","author":"A MacNeil","year":"2009","unstructured":"MacNeil A, Reynolds MG, Braden Z, Carroll DS, Bostik V, Karem K, et al. Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. Clin Infect Dis. 2009;48(1):e1-6. https:\/\/doi.org\/10.1086\/595552.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1048_CR108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","volume":"4","author":"DB Di Giulio","year":"2004","unstructured":"Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004;4(1):15\u201321. https:\/\/doi.org\/10.1016\/S1473-3099(03)00856-9.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1048_CR109","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jviromet.2010.07.012","volume":"169","author":"Y Li","year":"2010","unstructured":"Li Y, Zhao H, Wilkins K, Hughes C, Damon IK. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virol Methods. 2010;169(1):223\u201330. https:\/\/doi.org\/10.1016\/j.jviromet.2010.07.012.","journal-title":"J Virol Methods"},{"issue":"2","key":"1048_CR110","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4269\/ajtmh.16-0567","volume":"96","author":"D Li","year":"2017","unstructured":"Li D, Wilkins K, McCollum AM, Osadebe L, Kabamba J, Nguete B, et al. Evaluation of the GeneXpert for human monkeypox diagnosis. Am J Trop Med Hyg. 2017;96(2):405\u201310. https:\/\/doi.org\/10.4269\/ajtmh.16-0567.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1048_CR111","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.mcp.2009.10.008","volume":"24","author":"K Schroeder","year":"2010","unstructured":"Schroeder K, Nitsche A. Multicolour, multiplex real-time PCR assay for the detection of human-pathogenic poxviruses. Mol Cell Probes. 2010;24(2):110\u20133. https:\/\/doi.org\/10.1016\/j.mcp.2009.10.008.","journal-title":"Mol Cell Probes"},{"issue":"3","key":"1048_CR112","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jcv.2006.03.012","volume":"36","author":"Y Li","year":"2006","unstructured":"Li Y, Olson VA, Laue T, Laker MT, Damon IK. Detection of monkeypox virus with real-time PCR assays. J Clin Virol. 2006;36(3):194\u2013203. https:\/\/doi.org\/10.1016\/j.jcv.2006.03.012.","journal-title":"J Clin Virol"},{"issue":"9","key":"1048_CR113","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/labinvest.3700143","volume":"84","author":"DA Kulesh","year":"2004","unstructured":"Kulesh DA, Loveless BM, Norwood D, Garrison J, Whitehouse CA, Hartmann C, et al. Monkeypox virus detection in rodents using real-time 3\u2032-minor groove binder TaqMan assays on the Roche LightCycler. Lab Invest J Tech Methods Pathol. 2004;84(9):1200\u20138. https:\/\/doi.org\/10.1038\/labinvest.3700143.","journal-title":"Lab Invest J Tech Methods Pathol"},{"issue":"10","key":"1048_CR114","doi-asserted-by":"publisher","first-page":"e01524","DOI":"10.1128\/MRA.01524-19","volume":"9","author":"I Cohen-Gihon","year":"2020","unstructured":"Cohen-Gihon I, Israeli O, Shifman O, Erez N, Melamed S, Paran N, et al. Identification and whole-genome sequencing of a monkeypox virus strain isolated in Israel. Microbiol Resour Announc. 2020;9(10):e01524-e1619. https:\/\/doi.org\/10.1128\/MRA.01524-19.","journal-title":"Microbiol Resour Announc"},{"issue":"1","key":"1048_CR115","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmi.2025.09.011","volume":"32","author":"J Fuchs","year":"2026","unstructured":"Fuchs J, Bertelli C, Pillonel T, Cordeiro R, Izopet J, Pasquier C, et al. European pilot interlaboratory comparison study on Mpox virus whole genome sequencing. Clin Microbiol Infect. 2026;32(1):181\u20134. https:\/\/doi.org\/10.1016\/j.cmi.2025.09.011.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1048_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096930","volume":"9","author":"C Dumont","year":"2014","unstructured":"Dumont C, Irenge LM, Magazani EK, Garin D, Muyembe JJT, Bentahir M, et al. Simple technique for in-field sample collection in the cases of skin rash illness and subsequent PCR detection of orthopoxviruses and varicella zoster virus. PLoS ONE. 2014;9(5):e96930. https:\/\/doi.org\/10.1371\/journal.pone.0096930.","journal-title":"PLoS ONE"},{"issue":"1","key":"1048_CR117","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2019.03.015","volume":"95","author":"SD Davi","year":"2019","unstructured":"Davi SD, Kissenk\u00f6tter J, Faye M, B\u00f6hlken-Fascher S, Stahl-Hennig C, Faye O, et al. Recombinase polymerase amplification assay for rapid detection of monkeypox virus. Diagn Microbiol Infect Dis. 2019;95(1):41\u20135. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.03.015.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"1048_CR118","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/jmv.21494","volume":"81","author":"I Iizuka","year":"2009","unstructured":"Iizuka I, Saijo M, Shiota T, Ami Y, Suzaki Y, Nagata N, et al. Loop-mediated isothermal amplification-based diagnostic assay for monkeypox virus infections. J Med Virol. 2009;81(6):1102\u20138. https:\/\/doi.org\/10.1002\/jmv.21494.","journal-title":"J Med Virol"},{"issue":"4","key":"1048_CR119","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jaad.2022.12.027","volume":"88","author":"FJ Rodr\u00edguez-Cuadrado","year":"2023","unstructured":"Rodr\u00edguez-Cuadrado FJ, N\u00e1jera L, Su\u00e1rez D, Silvestre G, Garc\u00eda-Fresnadillo D, Roustan G, et al. Clinical, histopathologic, immunohistochemical, and electron microscopic findings in cutaneous monkeypox: a multicenter retrospective case series in Spain. J Am Acad Dermatol. 2023;88(4):856\u201363. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.027.","journal-title":"J Am Acad Dermatol"},{"key":"1048_CR120","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/microorganisms11071781","volume":"11","author":"C Moltrasio","year":"2023","unstructured":"Moltrasio C, Boggio F, Romagnuolo M, Cagliani R, Sironi M, Benedetto A, et al. Monkeypox: a histopathological and transmission electron microscopy study. Microorganisms. 2023;11:1781. https:\/\/doi.org\/10.3390\/microorganisms11071781.","journal-title":"Microorganisms"},{"issue":"8","key":"1048_CR121","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/cup.14398","volume":"50","author":"A Ortins-Pina","year":"2023","unstructured":"Ortins-Pina A, Hegemann B, Saggini A, Deml KF, Wallerius K, H\u00f6rster S, et al. Histopathological features of human mpox: report of two cases and review of the literature. J Cutan Pathol. 2023;50(8):706\u201310. https:\/\/doi.org\/10.1111\/cup.14398.","journal-title":"J Cutan Pathol"},{"issue":"1","key":"1048_CR122","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0303-6987.2005.00254.x","volume":"32","author":"IB Bayer-Garner","year":"2005","unstructured":"Bayer-Garner IB. Monkeypox virus: histologic, immunohistochemical and electron-microscopic findings. J Cutan Pathol. 2005;32(1):28\u201334. https:\/\/doi.org\/10.1111\/j.0303-6987.2005.00254.x.","journal-title":"J Cutan Pathol"},{"issue":"3","key":"1048_CR123","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrmicro.2016.182","volume":"15","author":"CJ Houldcroft","year":"2017","unstructured":"Houldcroft CJ, Beale MA, Breuer J. Clinical and biological insights from viral genome sequencing. Nat Rev Microbiol. 2017;15(3):183\u201392. https:\/\/doi.org\/10.1038\/nrmicro.2016.182.","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"1048_CR124","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00705-023-05848-w","volume":"168","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chen Z. Mpox: a review of laboratory detection techniques. Arch Virol. 2023;168(8):221. https:\/\/doi.org\/10.1007\/s00705-023-05848-w.","journal-title":"Arch Virol"},{"issue":"2","key":"1048_CR125","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cid\/cit703","volume":"58","author":"AM McCollum","year":"2014","unstructured":"McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260\u20137. https:\/\/doi.org\/10.1093\/cid\/cit703.","journal-title":"Clin Infect Dis"},{"issue":"7589","key":"1048_CR126","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature16996","volume":"530","author":"J Quick","year":"2016","unstructured":"Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530(7589):228\u201332. https:\/\/doi.org\/10.1038\/nature16996.","journal-title":"Nature"},{"issue":"1","key":"1048_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28385","volume":"95","author":"Q Chen","year":"2023","unstructured":"Chen Q, Gul I, Liu C, Lei Z, Li X, Raheem MA, et al. CRISPR-Cas12-based field-deployable system for rapid detection of synthetic DNA sequence of the monkeypox virus genome. J Med Virol. 2023;95(1):e28385. https:\/\/doi.org\/10.1002\/jmv.28385.","journal-title":"J Med Virol"},{"issue":"1","key":"1048_CR128","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5334\/aogh.4580","volume":"90","author":"FO Rahim","year":"2024","unstructured":"Rahim FO, Fallah M, Jain U, Richardson ET, Ndembi N, Ngongo N, et al. Challenges and ongoing actions to address the mpox emergency in Africa. Ann Glob Health. 2024;90(1):137. https:\/\/doi.org\/10.5334\/aogh.4580.","journal-title":"Ann Glob Health"},{"key":"1048_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanafr.2026.100046","author":"YS Atrah","year":"2026","unstructured":"Atrah YS, Gumede N, Nyombe J, Dereje N, Cho WN, Mercy K, et al. Decentralizing testing capacity of mpox in Africa: a narrative review. Lancet Reg Health-Afr. 2026. https:\/\/doi.org\/10.1016\/j.lanafr.2026.100046.","journal-title":"Lancet Reg Health-Afr"},{"key":"1048_CR130","unstructured":"Africa Centres for Disease Control and Prevention. Statement on antigen rapid tests for mpox diagnosis, 30 October 2024. https:\/\/africacdc.org\/news-item\/statement-on-antigen-rapid-tests-for-mpox-diagnosis-30-october-2024\/."},{"issue":"12","key":"1048_CR131","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/labinvest.3780373","volume":"81","author":"GM Zaucha","year":"2001","unstructured":"Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest. 2001;81(12):1581\u2013600. https:\/\/doi.org\/10.1038\/labinvest.3780373.","journal-title":"Lab Invest"},{"issue":"38","key":"1048_CR132","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1073\/pnas.0800589105","volume":"105","author":"E Hammarlund","year":"2008","unstructured":"Hammarlund E, Dasgupta A, Pinilla C, Norori P, Fr\u00fch K, Slifka MK. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proc Natl Acad Sci U S A. 2008;105(38):14567\u201372. https:\/\/doi.org\/10.1073\/pnas.0800589105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"1048_CR133","doi-asserted-by":"publisher","first-page":"15190","DOI":"10.1073\/pnas.0405759101","volume":"101","author":"KH Rubins","year":"2004","unstructured":"Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW, et al. The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci U S A. 2004;101(42):15190\u20135. https:\/\/doi.org\/10.1073\/pnas.0405759101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"1048_CR134","doi-asserted-by":"publisher","first-page":"15196","DOI":"10.1073\/pnas.0405954101","volume":"101","author":"PB Jahrling","year":"2004","unstructured":"Jahrling PB, Hensley LE, Martinez MJ, LeDuc JW, Rubins KH, Relman DA, et al. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci U S A. 2004;101(42):15196\u2013200. https:\/\/doi.org\/10.1073\/pnas.0405954101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1048_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015615","volume":"6","author":"KH Rubins","year":"2011","unstructured":"Rubins KH, Hensley LE, Relman DA, Brown PO. Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS ONE. 2011;6(1):e15615. https:\/\/doi.org\/10.1371\/journal.pone.0015615.","journal-title":"PLoS ONE"},{"issue":"5","key":"1048_CR136","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1128\/JVI.01931-10","volume":"85","author":"RF Johnson","year":"2011","unstructured":"Johnson RF, Dyall J, Ragland DR, Huzella L, Byrum R, Jett C, et al. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route. J Virol. 2011;85(5):2112\u201325. https:\/\/doi.org\/10.1128\/JVI.01931-10.","journal-title":"J Virol"},{"issue":"12","key":"1048_CR137","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1128\/JVI.03726-13","volume":"88","author":"D Byrd","year":"2014","unstructured":"Byrd D, Shepherd N, Lan J, Hu N, Amet T, Yang K, et al. Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination. J Virol. 2014;88(12):6819\u201331. https:\/\/doi.org\/10.1128\/JVI.03726-13.","journal-title":"J Virol"},{"issue":"19","key":"1048_CR138","doi-asserted-by":"publisher","first-page":"10191","DOI":"10.1128\/JVI.00892-10","volume":"84","author":"NM Beauchamp","year":"2010","unstructured":"Beauchamp NM, Busick RY, Alexander-Miller MA. Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J Virol. 2010;84(19):10191\u20139. https:\/\/doi.org\/10.1128\/JVI.00892-10.","journal-title":"J Virol"},{"issue":"11","key":"1048_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002374","volume":"7","author":"MA Fischer","year":"2011","unstructured":"Fischer MA, Davies ML, Reider IE, Heipertz EL, Epler MR, Sei JJ, et al. CD11b+, Ly6G+ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection. PLoS Pathog. 2011;7(11):e1002374. https:\/\/doi.org\/10.1371\/journal.ppat.1002374.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1048_CR140","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.0105-2896.2010.00906.x","volume":"235","author":"S Paust","year":"2010","unstructured":"Paust S, Senman B, von Andrian UH. Adaptive immune responses mediated by natural killer cells. Immunol Rev. 2010;235(1):286\u201396. https:\/\/doi.org\/10.1111\/j.0105-2896.2010.00906.x.","journal-title":"Immunol Rev"},{"issue":"10","key":"1048_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077804","volume":"8","author":"H Song","year":"2013","unstructured":"Song H, Josleyn N, Janosko K, Skinner J, Reeves RK, Cohen M, et al. Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLoS ONE. 2013;8(10):e77804. https:\/\/doi.org\/10.1371\/journal.pone.0077804.","journal-title":"PLoS ONE"},{"issue":"4","key":"1048_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008505","volume":"16","author":"PL Earl","year":"2020","unstructured":"Earl PL, Americo JL, Moss B. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLoS Pathog. 2020;16(4):e1008505. https:\/\/doi.org\/10.1371\/journal.ppat.1008505.","journal-title":"PLoS Pathog"},{"issue":"5","key":"1048_CR143","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/mi.2014.2","volume":"7","author":"A Jayaraman","year":"2014","unstructured":"Jayaraman A, Jackson DJ, Message SD, Pearson RM, Aniscenko J, Caramori G, et al. IL-15 complexes induce NK cell and T cell responses independent of type I IFN signaling during rhinovirus infection. Mucosal Immunol. 2014;7(5):1151\u201364. https:\/\/doi.org\/10.1038\/mi.2014.2.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"1048_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0196-6553(82)90003-7","volume":"10","author":"MA Strassburg","year":"1982","unstructured":"Strassburg MA. The global eradication of smallpox. Am J Infect Control. 1982;10(2):53\u20139. https:\/\/doi.org\/10.1016\/0196-6553(82)90003-7.","journal-title":"Am J Infect Control"},{"issue":"1","key":"1048_CR145","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/infdis\/135.1.145","volume":"135","author":"JD Cherry","year":"1977","unstructured":"Cherry JD, McIntosh K, Connor JD, Benenson AS, Alling DW, Rolfe UT, et al. Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration Primary percutaneous vaccination. J Infect Dis. 1977;135(1):145\u201354. https:\/\/doi.org\/10.1093\/infdis\/135.1.145.","journal-title":"J Infect Dis"},{"issue":"1","key":"1048_CR146","first-page":"41","volume":"25","author":"CH Kempe","year":"1961","unstructured":"Kempe CH, Bowles C, Meiklejohn G, Berge TO, Vincent LSt, Babu BVS, et al. The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox. Bull World Health Organ. 1961;25(1):41\u20138.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1048_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","volume":"84","author":"BL Jacobs","year":"2009","unstructured":"Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, et al. Vaccinia virus vaccines: past, present and future. Antiviral Res. 2009;84(1):1\u201313. https:\/\/doi.org\/10.1016\/j.antiviral.2009.06.006.","journal-title":"Antiviral Res"},{"issue":"3","key":"1048_CR148","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","volume":"167","author":"I Gilchuk","year":"2016","unstructured":"Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell. 2016;167(3):684-694.e9. https:\/\/doi.org\/10.1016\/j.cell.2016.09.049.","journal-title":"Cell"},{"key":"1048_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-025-00708-6","volume":"53","author":"A Ganesan","year":"2025","unstructured":"Ganesan A, Arunagiri T, Mani S, Kumaran VR, Kannaiah KP, Chanduluru HK. From pox to protection: understanding monkeypox pathophysiology and immune resilience. Trop Med Health. 2025;53:33. https:\/\/doi.org\/10.1186\/s41182-025-00708-6.","journal-title":"Trop Med Health"},{"issue":"10","key":"1048_CR150","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1128\/CVI.00148-07","volume":"14","author":"KL Karem","year":"2007","unstructured":"Karem KL, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S, et al. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol. 2007;14(10):1318\u201327. https:\/\/doi.org\/10.1128\/CVI.00148-07.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"1048_CR151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","volume":"21","author":"MKL MacLeod","year":"2009","unstructured":"MacLeod MKL, Clambey ET, Kappler JW, Marrack P. CD4 memory T cells: what are they and what can they do? Semin Immunol. 2009;21(2):53\u201361. https:\/\/doi.org\/10.1016\/j.smim.2009.02.006.","journal-title":"Semin Immunol"},{"issue":"12","key":"1048_CR152","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.chom.2022.11.004","volume":"30","author":"A Grifoni","year":"2022","unstructured":"Grifoni A, Zhang Y, Tarke A, Sidney J, Rubiro P, Reina-Campos M, et al. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans. Cell Host Microbe. 2022;30(12):1662-1670.e4. https:\/\/doi.org\/10.1016\/j.chom.2022.11.004.","journal-title":"Cell Host Microbe"},{"issue":"20","key":"1048_CR153","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1128\/JVI.00304-15","volume":"89","author":"WD Arndt","year":"2015","unstructured":"Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV, et al. Evasion of the innate immune type I interferon system by monkeypox virus. J Virol. 2015;89(20):10489\u201399. https:\/\/doi.org\/10.1128\/JVI.00304-15.","journal-title":"J Virol"},{"issue":"2","key":"1048_CR154","doi-asserted-by":"publisher","first-page":"162","DOI":"10.47262\/BL\/8.2.20220513","volume":"8","author":"I Ahmad","year":"2022","unstructured":"Ahmad I, Khan H, Salman M, Rehman L, Khan S, Saddam D, et al. Modeling interaction between nonstructural protein 2 of Chikungunya virus and various protein factors of innate pathway. Biomed Lett. 2022;8(2):162\u20139. https:\/\/doi.org\/10.47262\/BL\/8.2.20220513.","journal-title":"Biomed Lett"},{"key":"1048_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104424","volume":"87","author":"H Li","year":"2023","unstructured":"Li H, Huang QZ, Zhang H, Liu ZX, Chen XH, Ye LL, et al. The landscape of immune response to monkeypox virus. EBioMedicine. 2023;87:104424. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104424.","journal-title":"EBioMedicine"},{"issue":"5963","key":"1048_CR156","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1126\/science.1183021","volume":"327","author":"A Iwasaki","year":"2010","unstructured":"Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291\u20135. https:\/\/doi.org\/10.1126\/science.1183021.","journal-title":"Science"},{"issue":"2","key":"1048_CR157","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ni1303","volume":"7","author":"T Kawai","year":"2006","unstructured":"Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7(2):131\u20137. https:\/\/doi.org\/10.1038\/ni1303.","journal-title":"Nat Immunol"},{"issue":"7","key":"1048_CR158","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.it.2005.05.004","volume":"26","author":"H Hengel","year":"2005","unstructured":"Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: new insights into IFN networks. Trends Immunol. 2005;26(7):396\u2013401. https:\/\/doi.org\/10.1016\/j.it.2005.05.004.","journal-title":"Trends Immunol"},{"issue":"4","key":"1048_CR159","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino AV, Kanno Y, O\u2019Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18(4):374\u201384. https:\/\/doi.org\/10.1038\/ni.3691.","journal-title":"Nat Immunol"},{"issue":"14","key":"1048_CR160","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00018-017-2520-2","volume":"74","author":"N Raftery","year":"2017","unstructured":"Raftery N, Stevenson NJ. Advances in anti-viral immune defence: revealing the importance of the IFN JAK\/STAT pathway. Cell Mol Life Sci. 2017;74(14):2525\u201335. https:\/\/doi.org\/10.1007\/s00018-017-2520-2.","journal-title":"Cell Mol Life Sci"},{"key":"1048_CR161","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.virol.2016.07.016","volume":"497","author":"WD Arndt","year":"2016","unstructured":"Arndt WD, White SD, Johnson BP, Huynh T, Liao J, Harrington H, et al. Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus. Virology. 2016;497:125\u201335. https:\/\/doi.org\/10.1016\/j.virol.2016.07.016.","journal-title":"Virology"},{"issue":"1","key":"1048_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07772-z","volume":"9","author":"B Hern\u00e1ez","year":"2018","unstructured":"Hern\u00e1ez B, Alonso-Lobo JM, Montanuy I, Fischer C, Sauer S, Sigal L, et al. A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding. Nat Commun. 2018;9(1):5440. https:\/\/doi.org\/10.1038\/s41467-018-07772-z.","journal-title":"Nat Commun"},{"issue":"2","key":"1048_CR163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2016.134","volume":"17","author":"J Felix","year":"2017","unstructured":"Felix J, Savvides SN. Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Nat Rev Immunol. 2017;17(2):112\u201329. https:\/\/doi.org\/10.1038\/nri.2016.134.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1048_CR164","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1096\/fj.09-144733","volume":"24","author":"MdelM Fern\u00e1ndez de Marco","year":"2010","unstructured":"Fern\u00e1ndez de Marco MdelM, Alejo A, Hudson P, Damon IK, Alcami A. The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. FASEB J. 2010;24(5):1479\u201388. https:\/\/doi.org\/10.1096\/fj.09-144733.","journal-title":"FASEB J"},{"issue":"1","key":"1048_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28251","volume":"95","author":"M Shafaati","year":"2023","unstructured":"Shafaati M, Zandi M. Human monkeypox (hMPXV) re-emergence: host immunity status and current vaccines landscape. J Med Virol. 2023;95(1):e28251. https:\/\/doi.org\/10.1002\/jmv.28251.","journal-title":"J Med Virol"},{"issue":"10","key":"1048_CR166","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jiph.2022.09.008","volume":"15","author":"H Ejaz","year":"2022","unstructured":"Ejaz H, Junaid K, Younas S, Abdalla AE, Bukhari SNA, Abosalif KOA, et al. Emergence and dissemination of monkeypox, an intimidating global public health problem. J Infect Public Health. 2022;15(10):1156\u201365. https:\/\/doi.org\/10.1016\/j.jiph.2022.09.008.","journal-title":"J Infect Public Health"},{"issue":"2","key":"1048_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106024","volume":"56","author":"CC Lai","year":"2020","unstructured":"Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56(2):106024. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106024.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"1048_CR168","first-page":"E77","volume":"15","author":"GF Mohammed","year":"2022","unstructured":"Mohammed GF, Al-Dhubaibi MS, Atef L. Cutaneous manifestations of coronavirus disease 2019: skin narratives and dialogues. J Clin Aesthet Dermatol. 2022;15(5):E77\u201381.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"1048_CR169","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","volume":"83","author":"EE Freeman","year":"2020","unstructured":"Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118\u201329. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.1016.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1048_CR170","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1473-3099(22)00662-4","volume":"23","author":"C Agrati","year":"2023","unstructured":"Agrati C, Cossarizza A, Mazzotta V, Grassi G, Casetti R, De Biasi S, et al. Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study. Lancet Infect Dis. 2023;23(3):320\u201330. https:\/\/doi.org\/10.1016\/S1473-3099(22)00662-4.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1048_CR171","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s41983-022-00563-w","volume":"58","author":"T Roushdy","year":"2022","unstructured":"Roushdy T. SARS-CoV-2 and monkeypox: what is common and what is not in a present pandemic versus a potential one-a neuropsychiatric narrative review. Egypt J Neurol Psychiatry Neurosurg. 2022;58(1):127. https:\/\/doi.org\/10.1186\/s41983-022-00563-w.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"issue":"4","key":"1048_CR172","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","volume":"53","author":"CC Lai","year":"2020","unstructured":"Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: the need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505\u201312. https:\/\/doi.org\/10.1016\/j.jmii.2020.05.013.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"1048_CR173","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/v16030325","volume":"16","author":"NL Bragazzi","year":"2024","unstructured":"Bragazzi NL, Woldegerima WA, Wu J, Converti M, Szarpak L, Crapanzano A, et al. Epidemiological and clinical characteristics of mpox in cisgender and transgender women and non-binary individuals assigned to the female sex at birth: a comprehensive, critical global perspective. Viruses. 2024;16(3):325. https:\/\/doi.org\/10.3390\/v16030325.","journal-title":"Viruses"},{"issue":"1","key":"1048_CR174","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-virology-021020-100558","volume":"7","author":"B Moss","year":"2020","unstructured":"Moss B. Investigating viruses during the transformation of molecular biology: part II. Annu Rev Virol. 2020;7(1):15\u201336. https:\/\/doi.org\/10.1146\/annurev-virology-021020-100558.","journal-title":"Annu Rev Virol"},{"issue":"1","key":"1048_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-022-00518-2","volume":"21","author":"RA Farahat","year":"2022","unstructured":"Farahat RA, Abdelaal A, Shah J, Ghozy S, Sah R, Bonilla-Aldana DK, et al. Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? Ann Clin Microbiol Antimicrob. 2022;21(1):26. https:\/\/doi.org\/10.1186\/s12941-022-00518-2.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1048_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1094346","volume":"13","author":"AE El-Qushayri","year":"2022","unstructured":"El-Qushayri AE, Reda A, Shah J. COVID-19 and monkeypox co-infection: a rapid systematic review. Front Immunol. 2022;13:1094346. https:\/\/doi.org\/10.3389\/fimmu.2022.1094346.","journal-title":"Front Immunol"},{"key":"1048_CR177","doi-asserted-by":"publisher","DOI":"10.48327\/mtsi.v5i1.2025.604","author":"L Amisi Kengea","year":"2025","unstructured":"Amisi Kengea L, Iheka Mbangu Ngwakaha B, Masamba Bikoki W, Ndumbi Temuangudi V, Nsinga Bungiena JC, Kape Kalume JJ, et al. Profil des cas de mpox identifi\u00e9s lors de la surveillance de la zone de sant\u00e9 Kokolo \u00e0 Kinshasa (RDC) d\u2019ao\u00fbt \u00e0 novembre 2024. M\u00e9decine Trop Sant\u00e9 Int. 2025. https:\/\/doi.org\/10.48327\/mtsi.v5i1.2025.604.","journal-title":"M\u00e9decine Trop Sant\u00e9 Int"},{"issue":"3","key":"1048_CR178","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/ANNALS-25-00036","volume":"179","author":"PA Cholli","year":"2026","unstructured":"Cholli PA, Zucker J, Vigil KJ, Minhaj FS, Weidle PJ, Taylor MM, et al. Long-term mpox sequelae 11 to 18 months after acute illness. Ann Intern Med. 2026;179(3):362\u201371. https:\/\/doi.org\/10.7326\/ANNALS-25-00036.","journal-title":"Ann Intern Med"},{"issue":"42","key":"1048_CR179","doi-asserted-by":"publisher","first-page":"2400632","DOI":"10.2807\/1560-7917.ES.2024.29.42.2400632","volume":"29","author":"N Lagerqvist","year":"2024","unstructured":"Lagerqvist N, Beser J, Bakonyi T, Gossner CM, Palm D. Diagnostic and surveillance testing capability for mpox in the EU\/EEA, September 2024. Euro Surveill. 2024;29(42):2400632. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.42.2400632.","journal-title":"Euro Surveill"},{"key":"1048_CR180","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/IDR.S504280","volume":"18","author":"S He","year":"2025","unstructured":"He S, Zhao J, Chen J, Liang J, Hu X, Zhang X, et al. Urogenital manifestations in mpox (monkeypox) infection: a comprehensive review of epidemiology, pathogenesis, and therapeutic approaches. Infect Drug Resist. 2025;18:209\u201326. https:\/\/doi.org\/10.2147\/IDR.S504280.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"1048_CR181","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5765\/jkacap.230064","volume":"35","author":"A Jaleel","year":"2024","unstructured":"Jaleel A, Farid G, Irfan H, Mahmood K, Baig S. A systematic review on the mental health status of patients infected with monkeypox virus. J Korean Acad Child Adolesc Psychiatry. 2024;35(2):107\u201318. https:\/\/doi.org\/10.5765\/jkacap.230064.","journal-title":"J Korean Acad Child Adolesc Psychiatry"},{"issue":"7917","key":"1048_CR182","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/d41586-022-01686-z","volume":"607","author":"M Kozlov","year":"2022","unstructured":"Kozlov M. Monkeypox in Africa: the science the world ignored. Nature. 2022;607(7917):17\u20138. https:\/\/doi.org\/10.1038\/d41586-022-01686-z.","journal-title":"Nature"},{"issue":"9","key":"1048_CR183","doi-asserted-by":"publisher","first-page":"232","DOI":"10.15585\/mmwr.mm7209a4","volume":"72","author":"AK Rao","year":"2023","unstructured":"Rao AK, Schrodt CA, Minhaj FS, Waltenburg MA, Cash-Goldwasser S, Yu Y, et al. Interim clinical treatment considerations for severe manifestations of mpox \u2014 United States, February 2023. MMWR Morb Mortal Wkly Rep. 2023;72(9):232\u201343. https:\/\/doi.org\/10.15585\/mmwr.mm7209a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1048_CR184","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2022.2113058","author":"MW McCarthy","year":"2022","unstructured":"McCarthy MW. Therapeutic strategies to address monkeypox. Expert Rev Anti Infect Ther. 2022. https:\/\/doi.org\/10.1080\/14787210.2022.2113058.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"1048_CR185","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.antiviral.2012.02.012","volume":"94","author":"MN Prichard","year":"2012","unstructured":"Prichard MN, Kern ER. Orthopoxvirus targets for the development of new antiviral agents. Antiviral Res. 2012;94(2):111\u201325. https:\/\/doi.org\/10.1016\/j.antiviral.2012.02.012.","journal-title":"Antiviral Res"},{"issue":"6","key":"1048_CR186","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2217\/17460794.3.6.595","volume":"3","author":"S Parker","year":"2008","unstructured":"Parker S, Handley L, Buller RM. Therapeutic and prophylactic drugs to treat orthopoxvirus infections. Future Virol. 2008;3(6):595\u2013605. https:\/\/doi.org\/10.2217\/17460794.3.6.595.","journal-title":"Future Virol"},{"issue":"2","key":"1048_CR187","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/AAC.01172-07","volume":"52","author":"WC Magee","year":"2008","unstructured":"Magee WC, Aldern KA, Hostetler KY, Evans DH. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand. Antimicrob Agents Chemother. 2008;52(2):586\u201397. https:\/\/doi.org\/10.1128\/AAC.01172-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"1048_CR188","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1201\/b13787-245","volume-title":"Kucers\u2019 the use of antibiotics","author":"G Andrei","year":"2010","unstructured":"Andrei G, Snoeck R, Pfaller MA. Cidofovir. In: Grayson ML, editor. Kucers\u2019 the use of antibiotics. 6th ed. Boca Raton (FL): CRC Press; 2010. p. 2403\u201328.","edition":"6th ed"},{"issue":"12","key":"1048_CR189","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/v2122803","volume":"2","author":"G Andrei","year":"2010","unstructured":"Andrei G, Snoeck R. Cidofovir activity against poxvirus infections. Viruses. 2010;2(12):2803\u201330. https:\/\/doi.org\/10.3390\/v2122803.","journal-title":"Viruses"},{"key":"1048_CR190","doi-asserted-by":"publisher","first-page":"28","DOI":"10.31646\/gbio.12","volume":"1","author":"J Yu","year":"2019","unstructured":"Yu J, Raj SM. Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review. Glob Biosecur. 2019;1:28. https:\/\/doi.org\/10.31646\/gbio.12.","journal-title":"Glob Biosecur"},{"issue":"1\u20132","key":"1048_CR191","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","volume":"57","author":"RO Baker","year":"2003","unstructured":"Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antivir Res. 2003;57(1\u20132):13\u201323. https:\/\/doi.org\/10.1016\/S0166-3542(02)00196-1.","journal-title":"Antivir Res"},{"issue":"4","key":"1048_CR192","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","volume":"16","author":"E De Clercq","year":"2003","unstructured":"De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev. 2003;16(4):569\u201396. https:\/\/doi.org\/10.1128\/CMR.16.4.569-596.2003.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"1048_CR193","doi-asserted-by":"publisher","DOI":"10.3390\/v12020138","volume":"12","author":"H Meyer","year":"2020","unstructured":"Meyer H, Ehmann R, Smith GL. Smallpox in the post-eradication era. Viruses. 2020;12(2):138. https:\/\/doi.org\/10.3390\/v12020138.","journal-title":"Viruses"},{"issue":"7","key":"1048_CR194","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1128\/AAC.01489-05","volume":"50","author":"I Lebeau","year":"2006","unstructured":"Lebeau I, Andrei G, Dal Pozzo F, Beadle JR, Hostetler KY, De Clercq E, et al. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures. Antimicrob Agents Chemother. 2006;50(7):2525\u20139. https:\/\/doi.org\/10.1128\/AAC.01489-05.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1048_CR195","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","volume":"46","author":"ER Kern","year":"2002","unstructured":"Kern ER, Hartline C, Harden E, Keith K, Rodriguez N, Beadle JR, et al. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir. Antimicrob Agents Chemother. 2002;46(4):991\u20135. https:\/\/doi.org\/10.1128\/AAC.46.4.991-995.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7077","key":"1048_CR196","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nature04295","volume":"439","author":"KJ Stittelaar","year":"2006","unstructured":"Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, Hol\u00fd A, et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature. 2006;439(7077):745\u20138. https:\/\/doi.org\/10.1038\/nature04295.","journal-title":"Nature"},{"key":"1048_CR197","unstructured":"Huggins J, Raymond J, Fisher R, Jahrling P, Hensley L. Sequential determination of virus in blood and tissues of the variola cynomolgus monkey model of classical smallpox reveals that IV cidofovir can effectively treat monkeys with extensive viral burden. 19th International Conference on Antiviral Research; 2006. p. A36."},{"key":"1048_CR198","unstructured":"Huggins J, Martinez M, Hartmann C, Hensley L, Jackson D, Kefauver D, et al. Successful cidofovir treatment of smallpox-like disease in variola and monkeypox primate models. 17th International Conference on Antiviral Research. 2004."},{"issue":"8","key":"1048_CR199","first-page":"30","volume":"2","author":"US Food and Drug Administration","year":"1996","unstructured":"US Food and Drug Administration. FDA approves cidofovir for treatment of CMV retinitis. J Int Assoc Physicians AIDS Care. 1996;2(8):30\u20131.","journal-title":"J Int Assoc Physicians AIDS Care"},{"issue":"2\u20133","key":"1048_CR200","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0166-3542(95)00829-2","volume":"29","author":"M Wachsman","year":"1996","unstructured":"Wachsman M, Petty BG, Cundy KC, Jaffe HS, Fisher PE, Pastelak A, et al. Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. Antiviral Res. 1996;29(2\u20133):153\u201361. https:\/\/doi.org\/10.1016\/0166-3542(95)00829-2.","journal-title":"Antiviral Res"},{"issue":"6","key":"1048_CR201","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1128\/AAC.39.6.1247","volume":"39","author":"KC Cundy","year":"1995","unstructured":"Cundy KC, Petty BG, Flaherty J, Fisher PE, Polis MA, Wachsman M, et al. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1995;39(6):1247\u201352. https:\/\/doi.org\/10.1128\/AAC.39.6.1247.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1048_CR202","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/uog.24968","volume":"60","author":"A Khalil","year":"2022","unstructured":"Khalil A, Samara A, O\u2019Brien P, Morris E, Draycott T, Lees C, et al. Monkeypox and pregnancy: what do obstetricians need to know? Ultrasound Obstet Gynecol. 2022;60(1):22\u20137. https:\/\/doi.org\/10.1002\/uog.24968.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"1048_CR203","first-page":"150","volume":"39","author":"V B\u00edl\u00e1","year":"1993","unstructured":"B\u00edl\u00e1 V, Otov\u00e1 B, Jel\u00ednek R, Sladk\u00e1 M, Mejsnarov\u00e1 B, Hol\u00fd A, et al. Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA). Folia Biol (Praha). 1993;39(3):150\u201361.","journal-title":"Folia Biol (Praha)"},{"issue":"1","key":"1048_CR204","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1038\/s41467-022-32638-w","volume":"13","author":"A Khalil","year":"2022","unstructured":"Khalil A, Samara A, O\u2019Brien P, Ladhani S. Call for a unified approach to monkeypox infection in pregnancy: lessons from the COVID-19 pandemic. Nat Commun. 2022;13(1):5038. https:\/\/doi.org\/10.1038\/s41467-022-32638-w.","journal-title":"Nat Commun"},{"issue":"10","key":"1048_CR205","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","volume":"12","author":"DF Florescu","year":"2014","unstructured":"Florescu DF, Keck MA. Development of CMX001 (brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses. Expert Rev Anti Infect Ther. 2014;12(10):1171\u20138. https:\/\/doi.org\/10.1586\/14787210.2014.948847.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"1048_CR206","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/v2122740","volume":"2","author":"R Lanier","year":"2010","unstructured":"Lanier R, Trost L, Tippin T, Lampert B, Robertson A, Foster S, et al. Development of CMX001 for the treatment of poxvirus infections. Viruses. 2010;2(12):2740. https:\/\/doi.org\/10.3390\/v2122740.","journal-title":"Viruses"},{"issue":"1","key":"1048_CR207","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00927-20","volume":"6","author":"CL Hutson","year":"2021","unstructured":"Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN, et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. mSphere. 2021;6(1):e00927-20. https:\/\/doi.org\/10.1128\/mSphere.00927-20.","journal-title":"mSphere"},{"issue":"6","key":"1048_CR208","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","volume":"38","author":"TK Tippin","year":"2016","unstructured":"Tippin TK, Morrison ME, Brundage TM, Momm\u00e9ja-Marin H. Brincidofovir is not a substrate for the human organic anion transporter 1: a mechanistic explanation for the lack of nephrotoxicity observed in clinical studies. Ther Drug Monit. 2016;38(6):777\u201386. https:\/\/doi.org\/10.1097\/FTD.0000000000000353.","journal-title":"Ther Drug Monit"},{"key":"1048_CR209","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/bs.seda.2019.10.005","volume-title":"Side effects of drugs annual","author":"E Cani","year":"2019","unstructured":"Cani E, Park TE, Kavanagh R. Chapter 27 - antiviral drugs. In: Ray SD, editor. Side effects of drugs annual. Elsevier; 2019. p. 301\u201319. https:\/\/doi.org\/10.1016\/bs.seda.2019.10.005."},{"issue":"10","key":"1048_CR210","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/10600280231151751","volume":"57","author":"J Huston","year":"2023","unstructured":"Huston J, Curtis S, Egelund EF. Brincidofovir: a novel agent for the treatment of smallpox. Ann Pharmacother. 2023;57(10):1198\u2013206. https:\/\/doi.org\/10.1177\/10600280231151751.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"1048_CR211","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3201\/eid2608.191387","volume":"26","author":"SEF Yong","year":"2020","unstructured":"Yong SEF, Ng OT, Ho ZJM, Mak TM, Marimuthu K, Vasoo S, et al. Imported monkeypox, Singapore. Emerg Infect Dis. 2020;26(8):1826\u201330. https:\/\/doi.org\/10.3201\/eid2608.191387.","journal-title":"Emerg Infect Dis"},{"key":"1048_CR212","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Brincidofovir. https:\/\/www.aeped.es\/comite-medicamentos\/pediamecum\/brincidofovir."},{"issue":"2","key":"1048_CR213","doi-asserted-by":"publisher","first-page":"186","DOI":"10.53854\/liim-3102-6","volume":"31","author":"DT Ivanov","year":"2023","unstructured":"Ivanov DT, Slabakova YA, Argirova RM, Valkov TK. Antivirals for the treatment of monkeypox: utilization in the general and HIV-positive population and gaps for research A short narrative review. Infez Med. 2023;31(2):186\u201394. https:\/\/doi.org\/10.53854\/liim-3102-6.","journal-title":"Infez Med"},{"key":"1048_CR214","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.antiviral.2017.01.009","volume":"143","author":"G Chittick","year":"2017","unstructured":"Chittick G, Morrison M, Brundage T, Nichols WG. Short-term clinical safety profile of brincidofovir: a favorable benefit-risk proposition in the treatment of smallpox. Antiviral Res. 2017;143:269\u201377. https:\/\/doi.org\/10.1016\/j.antiviral.2017.01.009.","journal-title":"Antiviral Res"},{"key":"1048_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-110","volume":"7","author":"J Farlow","year":"2010","unstructured":"Farlow J, Ichou MA, Huggins J, Ibrahim S. Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypox virus. Virol J. 2010;7:110. https:\/\/doi.org\/10.1186\/1743-422X-7-110.","journal-title":"Virol J"},{"issue":"4","key":"1048_CR216","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00092-22","volume":"35","author":"S Elsayed","year":"2022","unstructured":"Elsayed S, Bondy L, Hanage WP. Monkeypox virus infections in humans. Clin Microbiol Rev. 2022;35(4):e0009222. https:\/\/doi.org\/10.1128\/cmr.00092-22.","journal-title":"Clin Microbiol Rev"},{"issue":"20","key":"1048_CR217","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","volume":"79","author":"G Yang","year":"2005","unstructured":"Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol. 2005;79(20):13139\u201349. https:\/\/doi.org\/10.1128\/JVI.79.20.13139-13149.2005.","journal-title":"J Virol"},{"issue":"9","key":"1048_CR218","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/infdis\/jiy326","volume":"218","author":"AT Russo","year":"2018","unstructured":"Russo AT, Grosenbach DW, Brasel TL, Baker RO, Cawthon AG, Reynolds E, et al. Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques. J Infect Dis. 2018;218(9):1490\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiy326.","journal-title":"J Infect Dis"},{"issue":"3","key":"1048_CR219","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021;19(3):331\u201344. https:\/\/doi.org\/10.1080\/14787210.2020.1819791.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"1048_CR220","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1128\/AAC.00977-13","volume":"57","author":"EM Mucker","year":"2013","unstructured":"Mucker EM, Goff AJ, Shamblin JD, Grosenbach DW, Damon IK, Mehal JM, et al. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (smallpox). Antimicrob Agents Chemother. 2013;57(12):6246\u201353. https:\/\/doi.org\/10.1128\/AAC.00977-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1048_CR221","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/v2112409","volume":"2","author":"R Jordan","year":"2010","unstructured":"Jordan R, Leeds JM, Tyavanagimatt S, Hruby DE. Development of ST-246\u00ae for treatment of poxvirus infections. Viruses. 2010;2(11):2409\u201335. https:\/\/doi.org\/10.3390\/v2112409.","journal-title":"Viruses"},{"issue":"17","key":"1048_CR222","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1128\/JVI.02173-10","volume":"85","author":"SK Smith","year":"2011","unstructured":"Smith SK, Self J, Weiss S, Carroll D, Braden Z, Regnery RL, et al. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus. J Virol. 2011;85(17):9176\u201387. https:\/\/doi.org\/10.1128\/JVI.02173-10.","journal-title":"J Virol"},{"issue":"7","key":"1048_CR223","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1128\/AAC.00208-15","volume":"59","author":"A Berhanu","year":"2015","unstructured":"Berhanu A, Prigge JT, Silvera PM, Honeychurch KM, Hruby DE, Grosenbach DW. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrob Agents Chemother. 2015;59(7):4296\u2013300. https:\/\/doi.org\/10.1128\/AAC.00208-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"1048_CR224","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-4939-9593-6_9","volume-title":"Vaccinia virus: methods and protocols","author":"DW Grosenbach","year":"2019","unstructured":"Grosenbach DW, Hruby DE. Preliminary screening and in vitro confirmation of orthopoxvirus antivirals. In: Mercer J, editor. Vaccinia virus: methods and protocols. New York (NY): Springer; 2019. p. 143\u201355. https:\/\/doi.org\/10.1007\/978-1-4939-9593-6_9."},{"issue":"5","key":"1048_CR225","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/jac\/dku545","volume":"70","author":"S Duraffour","year":"2015","unstructured":"Duraffour S, Lorenzo MM, Z\u00f6ller G, Topalis D, Grosenbach D, Hruby DE, et al. ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping. J Antimicrob Chemother. 2015;70(5):1367\u201380. https:\/\/doi.org\/10.1093\/jac\/dku545.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1048_CR226","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1128\/AAC.01303-07","volume":"52","author":"R Jordan","year":"2008","unstructured":"Jordan R, Tien D, Bolken TC, Jones KF, Tyavanagimatt SR, Strasser J, et al. Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor. Antimicrob Agents Chemother. 2008;52(5):1721\u20137. https:\/\/doi.org\/10.1128\/AAC.01303-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1048_CR227","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2217\/fvl.11.27","volume":"6","author":"DW Grosenbach","year":"2011","unstructured":"Grosenbach DW, Jordan R, Hruby DE. Development of the small-molecule antiviral ST-246\u00ae as a smallpox therapeutic. Future Virol. 2011;6(5):653\u201371. https:\/\/doi.org\/10.2217\/fvl.11.27.","journal-title":"Future Virol"},{"issue":"5","key":"1048_CR228","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/AAC.01596-08","volume":"53","author":"R Jordan","year":"2009","unstructured":"Jordan R, Goff A, Frimm A, Corrado ML, Hensley LE, Byrd CM, et al. ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother. 2009;53(5):1817\u201322. https:\/\/doi.org\/10.1128\/AAC.01596-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1048_CR229","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1128\/AAC.00904-12","volume":"56","author":"J Chinsangaram","year":"2012","unstructured":"Chinsangaram J, Honeychurch KM, Tyavanagimatt SR, Leeds JM, Bolken TC, Jones KF, et al. Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers. Antimicrob Agents Chemother. 2012;56(9):4900\u20135. https:\/\/doi.org\/10.1128\/AAC.00904-12.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1048_CR230","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","volume":"379","author":"DW Grosenbach","year":"2018","unstructured":"Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med. 2018;379(1):44\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1705688.","journal-title":"N Engl J Med"},{"issue":"8","key":"1048_CR231","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023237","volume":"6","author":"Y Chen","year":"2011","unstructured":"Chen Y, Amantana A, Tyavanagimatt SR, Zima D, Yan XS, Kasi G, et al. Comparison of the safety and pharmacokinetics of ST-246\u00ae after IV infusion or oral administration in mice, rabbits and monkeys. PLoS ONE. 2011;6(8):e23237. https:\/\/doi.org\/10.1371\/journal.pone.0023237.","journal-title":"PLoS ONE"},{"issue":"4","key":"1048_CR232","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061514","volume":"8","author":"A Amantana","year":"2013","unstructured":"Amantana A, Chen Y, Tyavanagimatt SR, Jones KF, Jordan R, Chinsangaram J, et al. Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection. PLoS ONE. 2013;8(4):e61514. https:\/\/doi.org\/10.1371\/journal.pone.0061514.","journal-title":"PLoS ONE"},{"issue":"11","key":"1048_CR233","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113577","volume":"27","author":"GA Oleinik","year":"2022","unstructured":"Oleinik GA, Koval VV, Usova SV, Shishkina LN, Chernonosov AA. Development and validation of a method of liquid chromatography coupled with tandem mass spectrometry for quantification of ST-246 (tecovirimat) in human plasma. Molecules. 2022;27(11):3577. https:\/\/doi.org\/10.3390\/molecules27113577.","journal-title":"Molecules"},{"issue":"5","key":"1048_CR234","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/infdis\/jiq103","volume":"203","author":"S Altmann","year":"2011","unstructured":"Altmann S, Brandt CR, Murphy CJ, Patnaikuni R, Takla T, Toomey M, et al. Evaluation of therapeutic interventions for vaccinia virus keratitis. J Infect Dis. 2011;203(5):683\u201390. https:\/\/doi.org\/10.1093\/infdis\/jiq103.","journal-title":"J Infect Dis"},{"issue":"1","key":"1048_CR235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-024-02117-1","volume":"85","author":"Y Rizk","year":"2025","unstructured":"Rizk Y, Lippi G, Henry BM, Notarte KI, Rizk JG. Update on mpox management: epidemiology, vaccines and therapeutics, and regulatory changes. Drugs. 2025;85(1):1\u20139. https:\/\/doi.org\/10.1007\/s40265-024-02117-1.","journal-title":"Drugs"},{"issue":"4","key":"1048_CR236","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041106","volume":"11","author":"SA Hudu","year":"2023","unstructured":"Hudu SA, Alshrari AS, Al Qtaitat A, Imran M. VP37 protein inhibitors for mpox treatment: highlights on recent advances, patent literature, and future directions. Biomedicines. 2023;11(4):1106. https:\/\/doi.org\/10.3390\/biomedicines11041106.","journal-title":"Biomedicines"},{"issue":"1","key":"1048_CR237","doi-asserted-by":"publisher","first-page":"e28306","DOI":"10.1002\/jmv.28306","volume":"95","author":"AA Rabaan","year":"2023","unstructured":"Rabaan AA, Abas AH, Tallei TE, Al-Zaher MA, Al-Sheef NM, Fatimawali, et al. Monkeypox outbreak 2022: what we know so far and its potential drug targets and management strategies. J Med Virol. 2023;95(1):e28306. https:\/\/doi.org\/10.1002\/jmv.28306.","journal-title":"J Med Virol"},{"issue":"1","key":"1048_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00395-y","volume":"9","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang JY, Wang FS. Monkeypox outbreak: a novel threat after COVID-19? Mil Med Res. 2022;9(1):29. https:\/\/doi.org\/10.1186\/s40779-022-00395-y.","journal-title":"Mil Med Res"},{"issue":"4","key":"1048_CR239","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01683-19","volume":"64","author":"D Delaune","year":"2020","unstructured":"Delaune D, Iseni F. Drug development against smallpox: present and future. Antimicrob Agents Chemother. 2020;64(4):e01683-19. https:\/\/doi.org\/10.1128\/AAC.01683-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1048_CR240","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.3390\/v2102381","volume":"2","author":"Y Xiao","year":"2010","unstructured":"Xiao Y, Isaacs SN. Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections. Viruses. 2010;2(10):2381\u201397. https:\/\/doi.org\/10.3390\/v2102381.","journal-title":"Viruses"},{"key":"1048_CR241","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.omtn.2022.05.025","volume":"28","author":"EM Mucker","year":"2022","unstructured":"Mucker EM, Thiele-Suess C, Baumhof P, Hooper JW. Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits. Mol Ther Nucleic Acids. 2022;28:847\u201358. https:\/\/doi.org\/10.1016\/j.omtn.2022.05.025.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"1048_CR242","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006581","volume":"12","author":"EM Mucker","year":"2018","unstructured":"Mucker EM, Wollen-Roberts SE, Kimmel A, Shamblin J, Sampey D, Hooper JW. Intranasal monkeypox marmoset model: prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Negl Trop Dis. 2018;12(6):e0006581. https:\/\/doi.org\/10.1371\/journal.pntd.0006581.","journal-title":"PLoS Negl Trop Dis"},{"issue":"21","key":"1048_CR243","doi-asserted-by":"publisher","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","volume":"79","author":"S Lustig","year":"2005","unstructured":"Lustig S, Fogg C, Whitbeck JC, Eisenberg RJ, Cohen GH, Moss B. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge. J Virol. 2005;79(21):13454\u201362. https:\/\/doi.org\/10.1128\/JVI.79.21.13454-13462.2005.","journal-title":"J Virol"},{"key":"1048_CR244","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00183","volume":"9","author":"HS Dai","year":"2018","unstructured":"Dai HS, Caligiuri MA. Molecular basis for the recognition of herpes simplex virus type 1 infection by human natural killer cells. Front Immunol. 2018;9:183. https:\/\/doi.org\/10.3389\/fimmu.2018.00183.","journal-title":"Front Immunol"},{"issue":"5571","key":"1048_CR245","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.1070884","volume":"296","author":"H Arase","year":"2002","unstructured":"Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296(5571):1323\u20136. https:\/\/doi.org\/10.1126\/science.1070884.","journal-title":"Science"},{"key":"1048_CR246","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01512","volume":"11","author":"M Market","year":"2020","unstructured":"Market M, Angka L, Martel AB, Bastin D, Olanubi O, Tennakoon G, et al. Flattening the COVID-19 curve with natural killer cell-based immunotherapies. Front Immunol. 2020;11:1512. https:\/\/doi.org\/10.3389\/fimmu.2020.01512.","journal-title":"Front Immunol"},{"issue":"2","key":"1048_CR247","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040030","volume":"4","author":"M Fang","year":"2008","unstructured":"Fang M, Lanier LL, Sigal LJ. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog. 2008;4(2):e30. https:\/\/doi.org\/10.1371\/journal.ppat.0040030.","journal-title":"PLoS Pathog"},{"issue":"1","key":"1048_CR248","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-5","volume":"9","author":"SC Johnston","year":"2012","unstructured":"Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A, Hensley LE. In vitro inhibition of monkeypox virus production and spread by interferon-\u03b2. Virol J. 2012;9(1):5. https:\/\/doi.org\/10.1186\/1743-422X-9-5.","journal-title":"Virol J"},{"issue":"Pt 1","key":"1048_CR249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.83391-0","volume":"89","author":"RE Randall","year":"2008","unstructured":"Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus countermeasures. J Gen Virol. 2008;89(Pt 1):1\u201347. https:\/\/doi.org\/10.1099\/vir.0.83391-0.","journal-title":"J Gen Virol"},{"issue":"9","key":"1048_CR250","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm917","volume":"9","author":"E Hammarlund","year":"2003","unstructured":"Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9(9):1131\u20137. https:\/\/doi.org\/10.1038\/nm917.","journal-title":"Nat Med"},{"issue":"10","key":"1048_CR251","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","volume":"171","author":"S Crotty","year":"2003","unstructured":"Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol. 2003;171(10):4969\u201373. https:\/\/doi.org\/10.4049\/jimmunol.171.10.4969.","journal-title":"J Immunol"},{"issue":"22","key":"1048_CR252","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","volume":"71","author":"AK Rao","year":"2022","unstructured":"Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(22):734\u201342. https:\/\/doi.org\/10.15585\/mmwr.mm7122e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1048_CR253","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jiph.2023.01.011","volume":"16","author":"MS Hakim","year":"2023","unstructured":"Hakim MS, Widyaningsih SA. The recent re-emergence of human monkeypox: would it become endemic beyond Africa? J Infect Public Health. 2023;16(3):332\u201340. https:\/\/doi.org\/10.1016\/j.jiph.2023.01.011.","journal-title":"J Infect Public Health"},{"issue":"50","key":"1048_CR254","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1016\/j.vaccine.2022.10.078","volume":"40","author":"L Priyamvada","year":"2022","unstructured":"Priyamvada L, Carson WC, Ortega E, Navarra T, Tran S, Smith TG, et al. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo. Vaccine. 2022;40(50):7321\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.078.","journal-title":"Vaccine"},{"issue":"11","key":"1048_CR255","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(23)00352-3","volume":"23","author":"H Cohn","year":"2023","unstructured":"Cohn H, Bloom N, Cai GY, Clark JJ, Tarke A, Berm\u00fadez-Gonz\u00e1lez MC, et al. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study. Lancet Infect Dis. 2023;23(11):1302\u201312. https:\/\/doi.org\/10.1016\/S1473-3099(23)00352-3.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1048_CR256","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1080\/22221751.2022.2095309","volume":"11","author":"Y Xiang","year":"2022","unstructured":"Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerg Microbes Infect. 2022;11(1):1768\u201377. https:\/\/doi.org\/10.1080\/22221751.2022.2095309.","journal-title":"Emerg Microbes Infect"},{"issue":"45","key":"1048_CR257","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1016\/j.vaccine.2015.09.067","volume":"33","author":"Y Nishiyama","year":"2015","unstructured":"Nishiyama Y, Fujii T, Kanatani Y, Shinmura Y, Yokote H, Hashizume S. Freeze-dried live attenuated smallpox vaccine prepared in cell culture \u201cLC16-KAKETSUKEN\u201d: post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. Vaccine. 2015;33(45):6120\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.067.","journal-title":"Vaccine"},{"key":"1048_CR258","unstructured":"World Health Organization. Vaccines and immunization for monkeypox: updated interim guidance, 24 August 2022. 2022. https:\/\/www.who.int\/news\/item\/24-08-2022-vaccines-and-immunization-for-monkeypox--interim-guidance--14-june-2022."},{"issue":"2","key":"1048_CR259","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","volume":"188","author":"M Engelstad","year":"1992","unstructured":"Engelstad M, Howard ST, Smith GL. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology. 1992;188(2):801\u201310. https:\/\/doi.org\/10.1016\/0042-6822(92)90535-W.","journal-title":"Virology"},{"issue":"17","key":"1048_CR260","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","volume":"24","author":"C Empig","year":"2006","unstructured":"Empig C, Kenner JR, Perret-Gentil M, Youree BE, Bell E, Chen A, et al. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine. 2006;24(17):3686\u201394. https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.029.","journal-title":"Vaccine"},{"issue":"Pt 12","key":"1048_CR261","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1099\/vir.0.2008\/004440-0","volume":"89","author":"CM Midgley","year":"2008","unstructured":"Midgley CM, Putz MM, Weber JN, Smith GL. Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol. 2008;89(Pt 12):2992\u20137. https:\/\/doi.org\/10.1099\/vir.0.2008\/004440-0.","journal-title":"J Gen Virol"},{"issue":"2","key":"1048_CR262","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/vaccines9020115","volume":"9","author":"JM Lozano","year":"2021","unstructured":"Lozano JM, Rodr\u00edguez Parra Z, Hern\u00e1ndez-Mart\u00ednez S, Yasnot-Acosta MF, Rojas AP, Mar\u00edn-Waldo LS, et al. The search of a malaria vaccine: the time for modified immuno-potentiating probes. Vaccines (Basel). 2021;9(2):115. https:\/\/doi.org\/10.3390\/vaccines9020115.","journal-title":"Vaccines (Basel)"},{"issue":"6160","key":"1048_CR263","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/332158a0","volume":"332","author":"ME Patarroyo","year":"1988","unstructured":"Patarroyo ME, Amador R, Clavijo P, Moreno A, Guzman F, Romero P, et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988;332(6160):158\u201361. https:\/\/doi.org\/10.1038\/332158a0.","journal-title":"Nature"},{"issue":"9","key":"1048_CR264","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41587-022-01463-3","volume":"40","author":"C Harrison","year":"2022","unstructured":"Harrison C. Monkeypox response relies on three vaccine suppliers. Nat Biotechnol. 2022;40(9):1306\u20137. https:\/\/doi.org\/10.1038\/s41587-022-01463-3.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"1048_CR265","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/infdis\/jir527","volume":"204","author":"JS Kennedy","year":"2011","unstructured":"Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, et al. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis. 2011;204(9):1395\u2013402. https:\/\/doi.org\/10.1093\/infdis\/jir527.","journal-title":"J Infect Dis"},{"key":"1048_CR266","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300290","author":"E Morino","year":"2024","unstructured":"Morino E, Mine S, Tomita N, Uemura Y, Shimizu Y, Saito S, et al. Mpox neutralizing antibody response to LC16m8 vaccine in healthy adults. NEJM Evid. 2024. https:\/\/doi.org\/10.1056\/EVIDoa2300290.","journal-title":"NEJM Evid"},{"key":"1048_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106027","volume":"176","author":"A Letafati","year":"2023","unstructured":"Letafati A, Sakhavarz T. Monkeypox virus: a review. Microb Pathog. 2023;176:106027. https:\/\/doi.org\/10.1016\/j.micpath.2023.106027.","journal-title":"Microb Pathog"},{"issue":"3","key":"1048_CR268","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1016\/S2666-5247(23)00365-8","volume":"5","author":"RF Fantin","year":"2024","unstructured":"Fantin RF, Coelho CH. Human antibody responses to circulating monkeypox virus emphasise the need for the first mpox-specific vaccine. Lancet Microbe. 2024;5(3):e204\u20135. https:\/\/doi.org\/10.1016\/S2666-5247(23)00365-8.","journal-title":"Lancet Microbe"},{"issue":"4","key":"1048_CR269","doi-asserted-by":"publisher","first-page":"429","DOI":"10.62940\/als.v9i4.1467","volume":"9","author":"SA Khan","year":"2023","unstructured":"Khan SA, Ahmad I, Khan W, Khan H, Abdullah AS. The contagious nature of SARS-CoV-2 Omicron variant and vaccine efficacy. Adv Life Sci. 2023;9(4):429\u201336. https:\/\/doi.org\/10.62940\/als.v9i4.1467.","journal-title":"Adv Life Sci"},{"issue":"11","key":"1048_CR270","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3390\/microorganisms11112713","volume":"11","author":"R Hirani","year":"2023","unstructured":"Hirani R, Noruzi K, Iqbal A, Hussaini AS, Khan RA, Harutyunyan A, et al. A review of the past, present, and future of the monkeypox virus: challenges, opportunities, and lessons from COVID-19 for global health security. Microorganisms. 2023;11(11):2713. https:\/\/doi.org\/10.3390\/microorganisms11112713.","journal-title":"Microorganisms"},{"issue":"1","key":"1048_CR271","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tips.2022.10.005","volume":"44","author":"JM Lozano","year":"2023","unstructured":"Lozano JM, Muller S. Monkeypox: potential vaccine development strategies. Trends Pharmacol Sci. 2023;44(1):15\u20139. https:\/\/doi.org\/10.1016\/j.tips.2022.10.005.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1048_CR272","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/PHH.0000000000001818","volume":"30","author":"GJ Bautista","year":"2024","unstructured":"Bautista GJ, Madera-Garcia V, Carter RJ, Schwitters A, Byrkit R, Carnes N, et al. Reducing vaccination disparities during a national emergency response: the US mpox vaccine equity pilot program. J Public Health Manag Pract. 2024;30(1):122\u20139. https:\/\/doi.org\/10.1097\/PHH.0000000000001818.","journal-title":"J Public Health Manag Pract"},{"key":"1048_CR273","unstructured":"Centers for Disease Control and Prevention. CDC Newsroom. 2022. CDC opening applications for Monkeypox Vaccine Equity Pilot Program. https:\/\/archive.cdc.gov\/www_cdc_gov\/media\/releases\/2022\/p0915-mpx-vaccine-equity.html."},{"key":"1048_CR274","volume-title":"Vaccines and immunization for monkeypox: interim guidance","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Vaccines and immunization for monkeypox: interim guidance. Geneva: World Health Organization; 2022."},{"key":"1048_CR275","unstructured":"U.S. Food and Drug Administration. Vaccines. Silver Spring (MD): U.S. Food and Drug Administration; 2025. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines."},{"issue":"43","key":"1048_CR276","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15585\/mmwr.mm7143e2","volume":"71","author":"JL Kriss","year":"2022","unstructured":"Kriss JL, Boersma PM, Martin E, Reed K, Adjemian J, Smith N, et al. Receipt of first and second doses of JYNNEOS vaccine for prevention of monkeypox-United States, May 22, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(43):1374\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7143e2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1048_CR277","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/inthealth\/ihaf018","volume":"17","author":"O Bolarinwa","year":"2025","unstructured":"Bolarinwa O, Mohammed A, Adebisi YA, Oyewo O. Left behind no more: ensuring equitable vaccine access to curb mpox in Africa. Int Health. 2025;17(4):594\u20136. https:\/\/doi.org\/10.1093\/inthealth\/ihaf018.","journal-title":"Int Health"},{"issue":"1","key":"1048_CR278","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4102\/jphia.v15i1.783","volume":"15","author":"N Ndembi","year":"2024","unstructured":"Ndembi N, Fol\u00e1yan MO. Now more than ever: Mpox renews the call for local pharmaceutical production for Africa\u2019s health security. J Public Health Afr. 2024;15(1):783. https:\/\/doi.org\/10.4102\/jphia.v15i1.783.","journal-title":"J Public Health Afr."},{"issue":"1","key":"1048_CR279","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.24-0606","volume":"112","author":"A Zumla","year":"2025","unstructured":"Zumla A, Rosenthal PJ, Sam-Agudu NA, Ogoina D, Mbala-Kingebeni P, Ntoumi F, et al. The 2024 Public Health Emergency of International Concern: a global failure to control mpox. Am J Trop Med Hyg. 2025;112(1):17\u201320. https:\/\/doi.org\/10.4269\/ajtmh.24-0606.","journal-title":"Am J Trop Med Hyg"},{"key":"1048_CR280","doi-asserted-by":"publisher","first-page":"251513552513143","DOI":"10.1177\/25151355251314339","volume":"13","author":"M Shafaati","year":"2025","unstructured":"Shafaati M, Forghani S, Shahsavand Davoudi A, Samiee R, Mohammadi K, Akbarpour S, et al. Current advances and challenges in mpox vaccine development: a global landscape. Ther Adv Vaccines Immunother. 2025;13:25151355251314340. https:\/\/doi.org\/10.1177\/25151355251314339.","journal-title":"Ther Adv Vaccines Immunother."},{"issue":"10460","key":"1048_CR281","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S0140-6736(24)02068-3","volume":"404","author":"I Abubakar","year":"2024","unstructured":"Abubakar I, Lutwama J, Kyobutungi C, Sankoh O. Mpox global emergency: strengthening African leadership. Lancet. 2024;404(10460):1286\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(24)02068-3.","journal-title":"Lancet"},{"issue":"1","key":"1048_CR282","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.glohj.2021.02.005","volume":"5","author":"RJ Fisk","year":"2021","unstructured":"Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Glob Health J. 2021;5(1):51\u20135. https:\/\/doi.org\/10.1016\/j.glohj.2021.02.005.","journal-title":"Glob Health J"},{"issue":"7","key":"1048_CR283","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac310","volume":"9","author":"BK Titanji","year":"2022","unstructured":"Titanji BK, Tegomoh B, Nematollahi S, Konomos M, Kulkarni PA. Monkeypox: a contemporary review for healthcare professionals. Open Forum Infect Dis. 2022;9(7):ofac310. https:\/\/doi.org\/10.1093\/ofid\/ofac310.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"1048_CR284","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1086\/498155","volume":"41","author":"A Nalca","year":"2005","unstructured":"Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005;41(12):1765\u201371. https:\/\/doi.org\/10.1086\/498155.","journal-title":"Clin Infect Dis"},{"key":"1048_CR285","unstructured":"Centers for Disease Control and Prevention. Isolation and infection control at home|Mpox|Poxvirus|CDC. 2023. https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/infection-control-home.html."},{"key":"1048_CR286","unstructured":"Centers for Disease Control and Prevention. Monitoring and risk assessment for persons exposed in the community|Mpox|Poxvirus|CDC. 2024. https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/monitoring.html."},{"key":"1048_CR287","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.22.22276713","author":"K Charniga","year":"2022","unstructured":"Charniga K, Masters N, Slayton R, Gosdin L, Minhaj F, Philpott D, et al. Estimating the incubation period of monkeypox virus during the 2022 multi-national outbreak. MedRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.06.22.22276713.","journal-title":"MedRxiv"},{"issue":"24","key":"1048_CR288","doi-asserted-by":"publisher","first-page":"2200448","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448","volume":"27","author":"F Miura","year":"2022","unstructured":"Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, de Coul EO, et al. Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Eurosurveillance. 2022;27(24):2200448. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.24.2200448.","journal-title":"Eurosurveillance"},{"issue":"10353","key":"1048_CR289","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(22)01487-8","volume":"400","author":"S Seang","year":"2022","unstructured":"Seang S, Burrel S, Todesco E, Leducq V, Monsel G, Le Pluart D, et al. Evidence of human-to-dog transmission of monkeypox virus. Lancet. 2022;400(10353):658\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(22)01487-8.","journal-title":"Lancet"},{"key":"1048_CR290","unstructured":"Centers for Disease Control and Prevention. Mpox in animals and pets|Mpox|Poxvirus|CDC. 2024. https:\/\/www.cdc.gov\/poxvirus\/mpox\/veterinarian\/mpox-in-animals.html."},{"key":"1048_CR291","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2025.101059","volume":"20","author":"DTS Hayman","year":"2025","unstructured":"Hayman DTS, Koopmans MPG, Cunningham AA, Bukachi SA, Masirika LM, Markotter W, et al. Mpox: a case study for a One Health approach to infectious disease prevention. One Health. 2025;20:101059. https:\/\/doi.org\/10.1016\/j.onehlt.2025.101059.","journal-title":"One Health"},{"issue":"2","key":"1048_CR292","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/COH.0000000000001005","volume":"21","author":"P Pathela","year":"2026","unstructured":"Pathela P, Nagao K, Braunstein S. Public health surveillance and outbreak preparedness for mpox. Curr Opin HIV AIDS. 2026;21(2):97. https:\/\/doi.org\/10.1097\/COH.0000000000001005.","journal-title":"Curr Opin HIV AIDS"},{"issue":"9","key":"1048_CR293","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1056\/NEJMoa2506495","volume":"394","author":"J Zucker","year":"2026","unstructured":"Zucker J, Fischer WA, Zheng L, McCarthy C, Saha PT, Javan AC, et al. Tecovirimat for the treatment of mpox. N Engl J Med. 2026;394(9):884\u201395. https:\/\/doi.org\/10.1056\/NEJMoa2506495.","journal-title":"N Engl J Med"},{"issue":"10","key":"1048_CR294","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13101071","volume":"13","author":"Q Quan","year":"2025","unstructured":"Quan Q, Wu N, Luo YH, Tang YJ, Liu YZ, Huang XC, et al. Global transmission, prevention, control, and treatment of mpox virus in 2025: a comprehensive review from infection mechanisms to vaccine development. Vaccines. 2025;13(10):1071. https:\/\/doi.org\/10.3390\/vaccines13101071.","journal-title":"Vaccines"},{"issue":"1","key":"1048_CR295","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12916-025-04350-1","volume":"23","author":"R Furst","year":"2025","unstructured":"Furst R, Antonio E, de Swart M, Foster I, Cerrado JP, Kadri-Alabi Z, et al. Gaps in the global health research landscape for mpox: an analysis of research activities and existing evidence. BMC Med. 2025;23(1):522. https:\/\/doi.org\/10.1186\/s12916-025-04350-1.","journal-title":"BMC Med"},{"key":"1048_CR296","doi-asserted-by":"publisher","DOI":"10.7326\/A21-0014","author":"RM Centor","year":"2022","unstructured":"Centor RM, Adalja A. Web exclusive Annals on call-Monkeypox: should we worry about another pandemic. Ann Intern Med. 2022. https:\/\/doi.org\/10.7326\/A21-0014.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1048_CR297","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/all.15393","volume":"77","author":"B Cabanillas","year":"2022","unstructured":"Cabanillas B, Valdelvira R, Akdis CA. Monkeypox outbreak in Europe, UK, North America, and Australia: a changing trend of a zoonotic disease. Allergy. 2022;77(8):2284\u20136. https:\/\/doi.org\/10.1111\/all.15393.","journal-title":"Allergy"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-026-01048-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-026-01048-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-026-01048-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:20:28Z","timestamp":1789032028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41182-026-01048-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":297,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1186\/s41182-026-01048-9","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"195"}}